{
  "name" : "twin.sci-hub.se_6575_90a2b84a593016227cf33c9a5e0fe0b6_amani2017.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries",
    "authors" : [ "Hamed Amani", "Rouhollah Habibey", "SJ Hajmiresmail", "Shahrzad Latifi", "Omid Akhavan" ],
    "emails" : [ "pazoki49@gmail.com;", "oakhavan@sharif.edu,", "omidakhawan@gmail.com" ],
    "sections" : [ {
      "heading" : null,
      "text" : "This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the author guidelines. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the ethical guidelines, outlined in our author and reviewer resource centre, still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains.\nAccepted Manuscript\nrsc.li/materials-b\nJournal of Materials Chemistry B Materials for biology and medicine www.rsc.org/MaterialsB\nISSN 2050-750X PAPER Guoping Chen et al. Regulating the stemness of mesenchymal stem cells by tuning micropattern features\nVolume 4 Number 1 7 January 2016 Pages 1–178\nJournal of Materials Chemistry B Materials for biology and medicine\nView Article Online View Journal\nThis article can be cited before page numbers have been issued, to do this please use: H. Amani, R. Habibey, S. Hajmiresmail, S. Latifi, H. Pazoki-Toroudi and O. Akhavan, J. Mater. Chem. B, 2017, DOI: 10.1039/C7TB01689A.\nAntioxidant nanomaterials in advanced diagnoses and treatments of\nischemia reperfusion injuries\nHamed Amani 1,2# , Rouhollah Habibey 3# , SJ Hajmiresmail 4 , Shahrzad Latifi 5 , Hamidreza Pazoki-\nToroudi 2* , Omid Akhavan 6*\n1 Department of medical nanotechnology, Faculty of Advanced Technologies in Medicine, Iran\nUniversity of Medical Science, Tehran, Iran\n2 Physiology Research Center and Department of Physiology, Faculty of Medicine, Iran\nUniversity of Medical Sciences, Tehran, Iran\n3 Department of Neuroscience and Brain Technologies (NBT), Italian Institute of Technology\n(IIT), via Morego 30, 16163 Genova, Italy\n4 Department of Cardiology, Iran University of Medical Sciences, Tehran, Iran.\n5 Department of Neurology, David Geffen School of Medicine, University of California Los\nAngeles, Los Angeles, California, USA\n6 Department of Physics, Sharif University of Technology, P.O. Box 11155-9161, Tehran, Iran\n__________________________________\n#These authors contributed equally to the work. *Correspondence to: Hamidreza Pazoki-Toroudi, Physiology Research Center, Iran University of Medical Sciences, P.O. Box 14515-763, Tehran, Iran. Fax: +98-21-88675760. Email: pazoki49@gmail.com; Omid Akhavan, Department of Physics, Sharif University of Technology, P.O. Box 11155-9161, Tehran, Iran. Tel.: +98-21-66164566, Fax: +98-21- 66022711, E-mail: oakhavan@sharif.edu, omidakhawan@gmail.com\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nAbstract\nOrgan ischemia with inadequate oxygen supply followed by reperfusion (which initiates a\ncomplex of inflammatory responses and oxidative stress) occurs in different clinical conditions\nand surgical procedures including stroke, myocardial infarction, limb ischemia, renal failure,\norgan transplantation, free-tissue-transfer, cardiopulmonary bypass, and vascular surgery. Even\nthough pharmacological treatment protect against experimental ischemia reperfusion (I/R) injury,\nthere has not been enough success for their applications in patient benefits. The main hurdles in\ntreatment of I/R injury are the lack of diagnosis tools for understanding the complicated chains\nof I/R-induced signaling events, especially in acute phase after ischemia, determining the\naffected regions of the tissue over time, and then, targeting and safe delivery of antioxidants,\ndrugs, peptides, genes and cells to the areas required treatment. Beside the innate antioxidant and\nfree radical scavenging properties of some nanoparticles, they show higher flexibilities in drug\ndelivery and imaging purposes. This review highlights three main approaches on I/R injury\ntargeting by nanoparticles; 1) antioxidant nanoparticles on reducing tissue oxidative stress, 2)\ntargeted delivery of therapeutic agents to the ischemic regions or cells, and 3) imaging I/R injury\nat molecular, cellular or tissue level and monitoring its evolution using contrasts induced by\nnanoparticles. These approaches can also be combined to realize so called theranostics for\nproviding simultaneous diagnosis of ischemic regions and treatments by targeted delivery.\nKeywords : Nanoparticles, Ischemia-reperfusion injury, Infarction, Nanomedicine, Drug\ndelivery, Diagnosis, Graphene materials\nTable of contents\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A"
    }, {
      "heading" : "1. Introduction",
      "text" : "1.1. Molecular mechanisms of ischemia reperfusion injury\n1.2. Tissue protection against ischemia reperfusion injury\n1.3. Nanomaterials: an advanced approach in treatment of ischemia reperfusion"
    }, {
      "heading" : "2. Antioxidant nanomaterials",
      "text" : "2.1. Metal and metal-oxide nanoparticles\n2.1.1. Cerium oxide (CeO2, ceria) nanoparticles\n2.1.2. Platinum nanoparticles (Pt Ns)\n2.1.3. Gold nanoparticles (Au NPs)\n2.1.4. Selenium nanoparticles (Se NPs)\n2.2. Carbon-based nanomaterials\n2.2.1. Fullerenes\n2.2.2. Graphene\n2.2.3. Nanotubes\n2.3. Polymeric nanoparticles\n3. Nanocarriers for drug delivery to I/R injury\n3.1. Liposome nanocarriers\n3.2. Polymer-based nanocarriers\n3.2.1. Polymer-drug or polymer-protein conjugates\n3.2.2. Polymeric micelles\n3.2.3. Polymeric nanocapsules\n3.2.4. Polymeric nanogels\n3.2.5. Dendrimers\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A"
    }, {
      "heading" : "4. Nanoparticles as imaging and diagnostic tools",
      "text" : "4.1. Metal and metal-oxide nanoparticles\n4.1.1. Iron oxide nanoparticles (IONPs)\n4.1.2. Gold nanoparticles\n4.2. Micelles for diagnosis of I/R injury\n4.3. Liposomes\n4.4. Polymeric nanoparticles and dendrimers\n4.5. Toxicity of nanomaterials\n4.6. Bloodstream circulation and clearance patterns of nanomaterials\n5. Outlook and conclusion\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A"
    }, {
      "heading" : "1. Introduction",
      "text" : "Ischemia reperfusion (I/R) is characterized by initial arterial occlusion, restriction of the blood supply to an organ, with subsequent perfusion. Organ ischemia is the underlying pathology for many clinical conditions including stroke, myocardial infarction, acute kidney injury, limb ischemia, solid organ transplantation, as well as cardiopulmonary and main arterial surgeries.1 Considering only myocardial infarction as a major cause of death and disability on the globe and lack of effective cardioprotective therapy in clinical practice necessitates the development of new therapies. 2"
    }, {
      "heading" : "1.1. Molecular mechanisms of ischemia reperfusion injury",
      "text" : "Ischemia or hypoxia induces oxidative stress, release of pro-inflammatory cytokines, subsequent cellular damages, and death. The reduction of tissue glucose and oxygen supplies which, in turn, results in low ATP level in cells. Oxidative stress and associated oxidative damage are leading causes of cellular injury in ischemic condition. Mediators of oxidative stress are reactive oxygen species (ROS) including superoxide radical anion, hydroxyl radical, singlet oxygen, and hydrogen peroxide that damage cellular targets such as DNA, proteins, and lipids. 3 After ischemia, reperfusion may cause a sequential chain of the pathophysiological cascades including massive intracellular Ca 2+ release, mitochondrial electron transport chain impairment, recruitment of neutrophils, acute inflammatory responses and generation of free radicals which, in turn, enhance apoptotic or necrotic cell death. 4"
    }, {
      "heading" : "1.2. Nanomaterials: an advanced approach in treatment of ischemia reperfusion",
      "text" : "The some strategies to reduce I/R-induced tissue damage relays on endogenous protection,\npharmacological treatments and the use of nano-scale devices. 5, 6 Varity of experimental\nischemic and pharmacological conditioning strategies have been tested in clinical settings over\npast 30 years and the results confirmed the challenges of translating the experimental findings to\npatients benefit. Rapidly developing field of nanotechnology offers promising future to\novercome the issues related to pharmacological treatment of ischemic tissue.7 Unique\nphysicochemical properties of materials at the nanolevel such as large surface-to-volume ratio,\nsurface chemistry, and possibility of targeted delivery to desired tissues make them good\ncandidates for biomedical applications. 8-10 The importance of the drug delivery in stroke and\nischemic disease emerge when managing the time is the most important parameter after\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nischemia. 11 Decreased blood flow to the affected tissue or its rapid metabolization by liver\ndecreases availability of the drug to the affected organ.12 Considering other barriers, e.g. blood\nbrain barrier (BBB) on stroke, the lack of an appropriate delivery system seems to be more\ncritical parameter in defining the outcome of damage. 13 Nanomaterials offer potentials for break\ndown of clots, efficient targeted delivery of stem cells and anti- ROS molcules to ischemic areas\nand their distribution, as well as decreasing its hepatic metabolization rate(figure1).14, 15\nfigure1. Various nanoplatforms for treatment of ischemic regions in heart tissue. Adapted\nfrom. 2\nMoreover, some nanoparticles shows antioxidant properties or they have been used as\ndiagnostic tools to detect the ischemic areas. 16, 17 In this paper potential uses of nanomaterials\nwill be discussed for diagnosis and the treatment of I/R injury of different organs. We\ncategorized their application in three subject 1) nanoparticles which show antioxidant properties,\n2) nanoparticles for targeted delivery of drugs to the ischemic regions, 3) nanoparticles on\ndiagnosis of I/R injury."
    }, {
      "heading" : "2. Antioxidant nanomaterials",
      "text" : "The endogenous antioxidant defence system of our body can neutralize the toxic effect of\nROS by both enzymatic (such as superoxide dismutase (SOD), catalase (CAT), glutathione\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nperoxidase, GSH-Px and glutathione-S-transferase (GST)) and non-enzymatic (such as\nglutathione) reactions.18 There are also external sources of antioxidants such as herbaceous\npolyphenols which play an important role against oxidative stress by targeting different cellular\nsignaling pathway and subsequently up-regulation of endogenous antioxidant defenses. 19-21\nRegarding the redox property of some nanoparticles, they can be exploited as possible\nbiologically active antioxidants. Owing to large surface area-to- volume ratio of nanomaterials,\nhigher ratios of active electrons can be found on the outer surface, resulting in increasing their\ncatalytic activity (here, antioxidant activity). 22 For instance, metal oxide nanomaterials can\npotentially be involved in effective ROS scavenging and/or deoxygenating reactions.23, 24 In\nrecent years, an increasing number of studies have emphasize d that nanomaterials can mimic the\nproperties of antioxidant enzymes to inhibit apoptosis and improve the cell survival after I/R\ninjury. 25, 26 In the light of these findings, a brief review on potential antioxidant activity of some\nnanomaterials is presented in the following."
    }, {
      "heading" : "2.1. Metal and metal-oxide nanoparticles",
      "text" : ""
    }, {
      "heading" : "2.1.1. Cerium oxide (CeO2, ceria) nanoparticles",
      "text" : "CeO2 is a metal oxide with potential redox activity, due to the quick mutations between\ncerium (IV), Ce 4+ , and cerium (III), Ce 3+ , oxidation states. In its bulk state, reduction of the Ce 4+\nto Ce 3+ leaves oxygen vacancies in the lattice, while the stabilized oxygen vacancies in NPs\nmakes it more effective at generating Ce 3+ . 27 As shown in figure 2, CeO2 NPs with oxygen\nbuffering properties in water give rise to excellent catalytic properties which mimics free-radical\nscavenging properties of the antioxidant enzymes and the activity of both superoxide oxidase and\ncatalase in scavenging the intracellular ROS and improve cell survival under oxidative stress. 28\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nMeantime, use of ultra-small nanoparticles with sizes < 4 nm significantly increases the catalytic\nactivity of CeO. 29 These NPs are also potent antioxidants with a substantial oxygen storage and\nrelease capacity via interchangeable surface. The redox cycle of the NPs results in their\naccumulation on the mitochondrial outer membrane and plasma membrane, resulting in\nprevention of amyloid beta-induced mitochondrial fragmentation in neural tissues (due to\ndecreasing both reactive nitrogen species (RNS) and ROS). 30, 31\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nFigure 2 a) Autocatalytic behavior of CeO NP in water, resulting in a general free-radical\nscavenging property b, c) high neuronal survival in treated cultures after 15 - 30 day and in th\nprecence of 100Mm H2O2 respectively. 32\nIt is also reported that CeO2 NPs accelerate the decay of peroxynitrite (ONOO−) that can\ngenerate hydroxyl and nitrogen dioxide radicals. Both of these potent radicals with an unpaired\nelectron can modulate oxidization of Ce 3+ to Ce 4+ at the particle surface with the continual\nrelease of hydroxyl ion or nitrite. 33\nIn the in vitro model of cardiac ischemia (H2O2 treated\ncardiac progenitor cells in dish), CeO NPs provided a strong and stable protection for 7 days\nwithout affecting their growth and function. 34 Recently, another report by Bailey et al.\ninvestigated the antioxidant mechanism of CeO NPs on traumatic brain injury outcome. They\nfound that CeO NPs improved neural survival and cognitive function via preservation of\nendogenous antioxidant systems and decreasing of macromolecular free radical damage. 35 On the\nother hand, down-regulation of pro-inflammatory cytokines by europium-doped Ceria NPs was\nfound to be associated with amelioration of intestinal IR injury. 36\nLikewise, Ce NPs possess phosphatase mimetic activity. The emerging evidence now show\nthat the chemistry and active sites of CeNPs involved in catalase mimetic activity are differ from\nthose involved in mimicking phosphatase. 37"
    }, {
      "heading" : "2.1.2. Platinum nanoparticles (PtNs)",
      "text" : "Platinum nanoparticles (Pt NPs) are extensively used in cosmetics because of their antioxidant\neffects. PtNs with high ratio of their surface free electrons are able to catalyze and quench\nsuperoxide anion and hydrogen peroxide by converting O2 ●- to H2O2, and H2O2 to H2O, and O2. 38\nThese properties of Pt NPs mimic the antioxidant enzymatic activity including peroxidase, SOD\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nand CAT (figure 3a). 39 For instance, PtNs strongly reduced the levels of intracellular O2 ●- and\nprotected HeLa cells from ROS-related death. 40 Likewise, the antioxidant mechanisms of Pt NPs\ncan be attributed to their mitochondrial complex I NADH ubiquinone oxidoreductase mimetic\nactivity, catechol oxidase-like activity and the ability to inhibit lipid peroxidation. 41 Similar to\nCeO NPs, Pt NPs exhibit a surface chemistry and size dependent antioxidant activity. For\nexample, Katsumi et al. reported that administrated smaller size (36 nm) of Pt NPs before liver\nI/R in mice model protected hepatic tissue against oxidative damage more than larger size\n(106 nm). 42\nOwing to in vitro antioxidant properties of Pt NPs, they have been applied for treatments of\nseveral models of organ ischemia reperfusion injuries. The Pt NPs has also been applied in\ntreatment of ischemic stroke on mice and strongly decreased ROS production in brain tissue,\ndecreased brain damage and ameliorated neurological functions (Figure 3b). 43, 44\nFigure 3 a) PtNPs catalyze three main antioxidant chemical reactions. Peroxidase (A), catalase\n(B), and superoxide dismutase (C) mimics. Adapted from ref.41 b) In vivo and ex vivo whole\nbrain fluorescence imaging of matrix metalloproteinase-9 (MMP-9) in vehicle and Pt NP treated\nmice 48 hours after transient cerebral ischemia, which shows restricted infraction size in the Pt\nNP treated mice. Adapted from ref. 45\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nNevertheless, a lot more careful studies should be carried out to understand the detailed\nmechanisms of the interactions between Pt NPs and chemical components of consumer products\nfor their safe applications in clinical trials. For instance, a recent study shows that the ascorbate\noxidase-mimetic activity of Pt NPs inhibits antioxidant activity of sodium L-ascorbate for\nscavenging of free radicals. 46"
    }, {
      "heading" : "2.1.3. Gold nanoparticles (GNPs)",
      "text" : "Among various metal nanoparticles, GNPs have further been studied and used in versatile\nbiological applications, because of being inert and resistance to surface oxidation. 47 The GNPs\nparadoxically and size-dependently act as both oxidants and antioxidants in biological systems. 48\nThe antioxidant property of GNPs has been confirmed in controlling the hyperglycemic\nconditions on diabetic mice by restoring antioxidant enzymes function (GSH, SOD, CAT and\nGPx), scavenging ROS and decreasing lipid peroxidation. 49 It has been shown that GNPs with\ndiameter of ~25 nm can ameliorate the production of oxidants, and decreases oxidative damages,\nwhile enhance the antioxidant defensive systems in adult rats. On cerebral ischemia reperfusion\nmodel, 20 nm GNPs administration resulted in remarkable reduction of infarction volume,\nincreasing the expression of the anti-inflammatory cytokines and anti-apoptotic proteins, as well\nas decreasing the expression of pro-apoptotic proteins. All of these confirmed in vivo antioxidant\nproperties on GNPs for cerebral ischemia models. 50 Furthermore, unique surface chemistry of\nGNPs provides possibility of their surface decoration with other ROS scavengers or anti-\ninflammatory agents to enhance their antioxidant activity in coping with I/R injury. 51\n2.1.4. Selenium nanoparticles (Se NPs)\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nSelenium (Se) which plays a critical role in redox reactions is known as an essential element\nin the health of mammalians. Se improves the activity of the selenoenzymes and delays onset and\nprogression of neurodegenerative diseases.52 In recent years Se NPs have attracted tremendous\ninterest from the scientific community as novel candidates in the management of oxidative stress\nowing to unique their properties including low toxicity, lots of surface active centers, excellent\nsurface activity, high catalytic efficiency and strong adsorbing ability. 53\nDirect antioxidant activity of Se NPs was already studied at three different size ranges; 5-15\nnm, 20-60 nm and 80-200 nm. The results showed that the Se NPs can effectively scavenge\ndifferent free radicals, such as superoxide anion, singlet oxygen and NO. The scavenging effect\nwas size dependent, namely, the smaller the stronger. 54 The antioxidant activity of Se NPs was\nalso studied on the in vitro models of ischemia reperfusion injury. The protective effect of Se\nNPs against oxidative stress is associated with alteration of the innate antioxidant status\n(glutathione, and antioxidant enzymes) and mitochondrial function. 55, 56 Even tough, the effect of Se\nNPs on in vivo models of I/R injury has remained to be clarified by future studies."
    }, {
      "heading" : "2.2. Carbon-based nanomaterials",
      "text" : "The carbon-based nanomaterials (often including graphene-based materials) comprise an\nextensive spectra of structures from zero-dimensional structures (fullerenes, diamond clusters),\nto one-dimensional (nanotubes), two-dimensional (graphene), and three-dimensional structures\n(nanocrystalline diamond, fullerite, and graphite) (figure 4a). Carbon-based nanomaterials can\ngenerate ROS because of the presence of the heteroatoms in chemically modified nanocarbons.57\nOn the other hand, carbon-based nanomaterials may also show ROS scavenging effects. 58 A\nhypothetic mechanism for antioxidant chemistry of graphene-based materials has been proposed\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nbased on radical adducts formation at sp 2 carbon sites, and its destruction during second adduct\nformation by electron transfer or hydrogen donation from functional groups.59"
    }, {
      "heading" : "2.2.1. Fullerenes",
      "text" : "The fullerene (one of the allotropes of carbon which usually forms as C60 and C70) is a\nsoccer ball-shaped carbon cage with unique surface chemistry that provides the possibility of its\nsimple and extensive surface decoration for biomedical applications. 60, 61 Chemical structure of\nfullerene with abundance of conjugated double bonds and low lying lowest unoccupied\nmolecular orbital (LUMO) makes it highly receptive to the radical species. Due to such catalytic\nproperty, fullerene can react with many superoxides without being consumed.62 Antioxidant\nfunctionality of fullerene depends on its ability for absorbing electrons and their dispersing\nthrough the 3D -conjugated structure distributed over its surface. 63 In fact, fullerenes behave as\n‘‘free radical sponges’’ and their micro molar concentrations can show antioxidant activity in\nelimination of both superoxide anion and H2O2. It is worth mentioning that π-conjugation of the\nfullerenols facilitate its covalent interaction with the –OH groups of different molecules such as\ncellulose nanocrystals(CNC) which, in turn, result in enhanced colloidal stability, reduced\ntendency to form clusters and higher accessibility to 2,2-diphenyl-1-picrylhydrazyl (DPPH) free\nradicals ( figure 4b). 64\nIn spite of superoxide dismutase (SOD) activity which may lead to excessive production of\nH2O2, fullerene coordinated effect on scavenging superoxide anion and H2O2 does not lead to\nincreased H2O2 production. 65 Emerging evidences show that fullerene C60 contribute to cell\nsurvival via alteration of the cellular redox state and enzyme activities. 66 Derivatizing fullerenes\nwith a polar group makes them water soluble, e.g. polyhydroxylated fullerenes (fullerenol) and\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\ncarboxyfullerenes. These fullerenes can pass the cell membrane and localize to the mitochondria\nwhich is the source of the oxygen free radicals.67 It has also been proved that carboxyfullerenes\nprevented from mitochondrial membrane disruption and leakage, which is the triggering step in\napoptosis. 68 Different derivatives of fullerenes have been applied to ischemic tissue to find out\ntheir potential effects on reducing oxidative damage and preserving tissue function after\nischemia(Table 1). Fullerenes C60 have most frequently been described as antioxidants,\nalthough in biological systems they can paradoxically act as both oxidants and antioxidants.\nThompson et al. reported that intratracheal or intravenous administration of C60 fullerene\nincreases myocardial infarction size and coronary artery contraction after cardiac I/R injury in\nrats. 69 For these controversial findings, size, structure and surface chemistry of fullerenes may\ndetermine their antioxidant activity and biological behavior if they contribute to cell survival\nagainst oxidative stress or enhance cancerous cell death. For instance, Hsu et al. demonstrated\nthat the different surface functional groups could exert distinct regulations of the oxygen\nmetabolism in target cells to induce or reduce the generation of ROS(figure 4 c). 70\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nFigure 4. a) Examples of carbon entities at nanoscale level; Graphene, Graphite, Carbon\nnanotubes (CNTs), and a buckminsterfullerene (C60). Adopted from ref. 71 b) Schematic illustrate\nof fullerol immobilization onto CNC. Adopted from ref. 64 c) Surface chemistry of fullerene\ndetermines either induce or reduce the oxidation. Adopted from ref. 70"
    }, {
      "heading" : "2.2.2. Graphene",
      "text" : "Graphene is a 2D monolayer of tightly packed carbon atoms with fascinating properties.72 Chemical modification of graphene by hydroxyl, epoxyl or carboxyl groups provides graphene oxide (GO) with some versatile and attractive properties as compared to the pristine graphene.73, 74 Graphene, due to its unique electron mobility, thermal conductivity, and biocompatibility,\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\noffers great potentials for upcoming nanomedicine, including detection of single nucleotide polymorphisms of DNA, early diagnosis of cancer, and cancer therapy. 75-77 The basic chemical activity of GO, reduced graphene oxide (rGO) and few-layer graphene (FLG) against different ROS were evaluated in a single study by Qui et al. 78 All graphene-based materials showed strong activity against hydroxyl (OH), modest activity against hydrogen peroxide and lipid peroxyl radicals and stable radicals including 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′- azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS). 79 OH radical scavenging capacity of graphen-based nanomaterials was in the following order; FLG>rGO>GO. 78 Pristine sp 2 -carbon domains are considered as the main radical scavenging site and acts through adduct formation or electron transfer. 80 Graphene-based materials also prevent from photochemical ROS production by absorbing UV (figure 5a). Although in some studies GO and rGO was found as the source of ROS generation, it was also found that the methods applied for GO reduction can affect and control the ROS level generated by rGO. 81 Therefore, antioxidant activity of graphene-based materials strongly depends on their electron density, chemical composition, sp 2 -hybridized carbon content and chemical properties (originated from the method used in the synthesis). For instance, the reduction of GO by herbal antioxidants enhances its antioxidant activity against scavenging of 1,1-Diphenyl-2- picrylhydrazyl (DPPH) free radicals. 82 In an another report by Ruiz et al. synthesized graphene quantum dots (GQD) with strong hydrogen donor behavior and large content of sp 2 -hybridized carbon domains exert higher ability than other types to scavenge free radical and ROS (Figure 5b,c,d). 83 Graphene can promisingly be applied in any kind of tissue injuries using stem cell-based tissue engineering or any other suitable techniques. 74, 84 ROS generated in the ischemic myocardium following reperfusion decrease survival of Mesenchymal stem cells ( MSCs) implanted to treat myocardial infarction (MI). Kim et al. studied the antioxidant mechanism of GO flakes for protection the implanted MSCs from ROSmediated death after MI. They found that GO flakes provided a platform for MSC adhesion and hampered a series of adverse cell-signaling cascades which, in turn, led to the anoikis of MSCs in response to ROS. 85 Graphene foam, as a 3D class of graphene architectures, has attracted much attention as a neural interface material because of its excellent topographical properties can provoke anti-inflammatory responses via the restriction of microglia morphological transformation on the surface. 86, 87 Moreover, there is a close association between antioxidant and free radical scavenging effects of graphene foam and its sp 2 -carbon network. The synergistic\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nantioxidant effects of vitamin C and graphene foam rescued the H2O2-impaired cell viability and differentiation of human bone marrow-derived mesenchymal stem cells under oxidative stress in a Wnt signaling pathway dependent mechanism. 88\nFigure. 5. Antioxidant mechanisms of graphene-based materials. a) Proposed antioxidant\nmechanisms include UV absorption, iron binding, ˙OH adduct formation on sp 2 -carbon sites,\nelectron transfer, and hydrogen donation. Graphene-based materials mainly act against ˙OH\nwhich is associated with pristine sp 2 -carbon domains. It also has been proved that antioxidant\nproperties of GO is related to its radical scavenging effects rather than inhibition of Fenton\nreaction by iron complexation at oxygen-containing functional groups. Adopted from ref. 78 b)\nChemistry of antioxidant activity of GQD. c) Chemical structures of three types of GQD and\ntheir sp 2 -hybridized carbon contents. d) Radical scavenging activity (RSA) of GQDp is much\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nhigher than other types owing to higher sp 2 -hybridized carbon contents and abundant edge\nfunctional groups. Adopted from ref. 83"
    }, {
      "heading" : "2.2.3. Nanotubes",
      "text" : "Carbon nanotubes (CNTs) are cylindrical molecules composed of one or more graphene layers (single-wall or multiwall). The extensive application of the CNTs is related to their chemical stability, electrical conductivity and mechanical strength. Regardless of their potential for industrial applications they can present cytotoxic.89 However, there are studies which suggested a ROS scavenging effect related to the conjugated C==C chains on the CNT structure which is similar to the carotenoids. 90 It has been shown that multiwall carbon nanotubes (MWCNTs) prevented from oxidation of the polystyrene, polyethylene and polypropylene. However, the effect was not as strong as the phenolic antioxidants. 91 Purified MWCNTs in aqueous solution showed strong capacity on scavenging the superoxide and hydroxyl radicals and this effect was independent on the source of the ROS. Despite the acute oxidative effect of PEGylated singlewall CNTs (SWCNT-PEG) on rat hippocampus, its long-term effect, one week after injection, appeared by increased expression of the antioxidant enzymes genes, improved antioxidant defense and reduced ROS production. 92 Such delayed antioxidant response to SWCNT-PEG proposed an adaptive, conditioning, response in tissue. This property of SWCNT-PEG can be utilized for pharmacological preconditioning against I/R injury, because it has already been proved that sublethal oxidative stress can increase tissue tolerance against lethal and sever ischemia. Putting all these together, there are open questions related to the application of CNTs to protect tissue against the oxidative stress. 93 The general mechanisms by which CNTs lead to cell toxicity has already been summarized on a review presented by Schedova et al., 2012. 94"
    }, {
      "heading" : "2.3. Polymeric nanoparticles",
      "text" : "Polymeric NPs consistently show new and unique properties compared to their bulk state, due to quantum effects at nanoscales and increased surface to volume ratio. Two major categories of polymeric nanostructures are nanospheres and nanocapsules. nanospheres are matrix particles with solid mass and nanocapsules are vesicular systems with cavity consisting of a liquid core,\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\neither water or oil.95 Even though, polymeric NPs does not provide direct antioxidant effects, but their involvement in antioxidant activities for tissue protection after I/R injury have been studied. 96, 97 In recent years, stimuli-responsive polymeric nanoparticles have shown great promise for treatment and detection of ischemic areas owing to changeability of their chemical structure and physicochemical properties in response to environmental stimuli including pH, ionic strength, temperature and light.98 The unique properties of ROS responsive polymeric nanoparticle such as the alteration in solubility in response to ROS and dual pH and ROSinduced degradation make them excellent candidates for ROS-responsive drug release or imaging of ischemic regions. 99 In the case of tellurium containing polymers, a ROS responsive polymeric nanoparticle, the oxidation of tellurium on the polymer backbone is account for the swelling and hydration of micelles in the presence of H2O2 (figure 6a,b). 100 The integration of aryloxalates via ester bond within the polymeric nanostructures contribute to their degradation and drug release in response to H2O2 because aryloxalates can react with H2O2 to form 1,2 dioxetanedione and subsequently decompose into carbon dioxide. 101\nMost of these studies chemically incorporated an antioxidant agent on fully biodegradable hydroxybenzyl alcohol (HBA) to develop the effective antioxidant NPs. In the case of HBAincorporated polyoxalate copolymer (HPOX), the antioxidant and anti-inflammatory effects of the HBA linked with H2O2 scavenging effects of polyoxalate copolymer. For instance, Lee et al. chemically incorporated HBA in the backbone of HPOX via covalent bonds to prepare an oxidation-responsive polymeric nanoparticle for detection and therapy of ischemia–reperfusion injury. The authors mentioned that HPOX can be used as H2O2 imaging agents because it is capable to react with H2O2 to perform peroxalate chemiluminescence reaction in the presence of fluorescent dyes(figure 6c). 102\nSimilar to the above-mentioned study, same group covalently incorporated vanillyl alcohol (VA) in the backbone of H2O2-responsive peroxalate ester to design a nanotherapeutic agent for I/R\ninjury and H2O2-associated disorders. 103 Similar to HPOX, PVAX was also exploited for H2O2 detection and imaging on ischemic tissue. The imaging section for this also could be bringing in related section. Moreover, same authors prepared poly (vanillin oxalate) (PVO) as a polymeric prodrug of vanillin (PVOX) to scavenge H2O2 and suppress generation of ROS under oxidative stress. As mentioned above, vanillin covalently (by both H2O2-responsive peroxalate ester bonds\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nand acid-cleavable acetal linkages) was incorporated in its backbone and gradually was released during its hydrolytic degradation under acidic conditions and presence of H2O2, two main characterizations of ischemic regions (figure 6d). 104 Moreover, polymer self-assembly method can be applied to design pH-responsive antioxidant nanoparticles to scavenge ROS. The resulting nanoparticle exhibits high stability at pH 7.4 while acidic conditions contribute to their solubility. 105\nFigure 6. a,b) morphological changes of tellurium-containing polymer micelles in response to ROS. Adopted from ref. 100, 106 H2O2-activatable nanoparticles could be exploited in parallel for imaging and therapy. c,d) HPOX and PVOX nanoparticles could be exploited as imaging probes for H2O2 detection, as antioxidant and anti-inflammatory releasing agents and as a cargo to deliver drugs to the injury site after I/R injury. Adopted from ref. 102, 104 Jo\nur\nna lo\nfM\nat\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A"
    }, {
      "heading" : "3. Nanocarriers for drug delivery to I/R injury",
      "text" : "Drug delivery is one of the most advanced applications of nanoparticles in medicine which is mainly based on polymer or liposome carriers. Nanocarriers could be harnessed for targeted delivery to specific organ or cells, increased solubility of the hydrophobic drugs, enhanced stability of peptides and oligonucleotides, as well as improved permeability and of drugs across blood brain barrier (BBB). 107 Different principles are used for carriers include dispersing or dissolving the drug within a polymer matrix, entrapping drug inside lipid vesicles, encapsulating or adsorbing the treatment agents on the nanoparticle surface (Figure 7). Main examples of polymer- and lipid- based drug delivery have been summarized in Table 2. In addition, there is two main strategies for site-specific drug delivery using nanocarriers; passive and active targeting. Passive targeting uses the unique vascular bed in the target organ or tissue to accumulate at that site, while on active targeting there are specific ligands on nanocarrier surface which binds to the extracellular markers of the target-cell. 108, 109 In the following, we mainly discuss the polymer- and liposome-based nanocarriers for the treatment of ischemic tissue injuries."
    }, {
      "heading" : "3.1. Liposome nanocarriers",
      "text" : "Liposomes are vesicular structures which mainly formed by self-assembly of the dissolved polar lipid molecules including hydrophobic and hydrophilic tails. Lipid-based nanovesciles can separate hydrophilic or hydrophobic molecules from the bulk solution. Beside their applications as carrier for cancer treatment, liposome NPs have also been used on delivery of drugs, proteins/peptides and genes to the ischemic site or cells. 110 Liposomes have been extensively applied as nanocarriers for targeted delivery of antioxidant agents. Numerous papers have shown that the physicochemical properties of liposomes such as charges, chemical composition, surface chemistry and surface functional groups determine their efficiency and behavior as nanocarriers for treatment and bioimaging of ischemic areas. Due to the acidic conditions in the cytosol of the ischemic cells and interstitial space of the ischemic tissue, basic lipids could be utilized for providing acid-sensitive nanoliposomes to release their cargos specifically in the ischemic site. 111 Phosphatidylethanolamines (PE)- and dioleoylphosphatidylethanolamine (DOPE)-based nanoliposomes are among the acidic sensitive liposomes which can release the encapsulated drugs on the ischemic penumbra. 112 The molecular shape of phospholipids and their high tendency for accumulation in inverse hexagonal phases instead of lamellar phases like in double layers result in their pH-sensitivity. 113 PH sensitive nanoliposomes are mainly stabilized with PEG to prevent from unwanted leakage or fusion, and equally increase their circulation time and therefore their bioavailability. Application of the naoliposomes for selective delivery of the\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\ntherapeutic agents to the ischemic brain regions is considered as a promising therapeutic approach. Nanoliposomes can cross the BBB by passive diffusion, through endocytosis, or by ligand-directed route. The liposome nanocarriers could be additionally functionalized for enhanced penetration through the BBB, increased circulation time and therefore increased bioavailability, as well as selectivity for the ischemic regions. These properties could decrease side effects and increase the efficacy of the drug. 114-116 Multifunctional liposomes can encompass all above mentioned characteristics by including pH-sensitive lipid-bases, PEGconjugation for increased circulation time as well as functional peptides for specific delivery. Studies on the cardiac I/R showed that positively charged liposomes passively accumulate on the ischemic regions of the myocardium, which later have extensively been utilized for selective delivery of drugs to the ischemic heart. 117-119 For instance, ATP-loaded liposome nanocarriers were specifically targeted the ischemic heart cells by antimyosin label and improved the systolic and diastolic pressure ex vivo and decreased infarct size in vivo. 120 Liposome conjugated ligand for angiotensin II type-1 receptor (AT1) specifically targeted the ischemic heart tissue which overexpresses AT1 receptors. 121 Nanoliposomes could also contain a solid matrix, including solid lipid nanoparticles (SLNPs) and nanostructured lipid carriers (NLCs). These nanomaterials can combine the advantages of polymeric NPs, fat emulsions, and liposomes. 122 Poor absorption and stability at physiological pH, rapid metabolism, and rapid clearance of some antioxidant agents decrease their efficiency to enhance cell survival in ischemic regions. Unique surface chemistry of SLNPs and their ability for drug loading provides new horizons to solve this problems. 123, 124 Engineered nanoliposomes encapsulated the basic fibroblast growth factor (bFGF) on their solid core were applied from intranasal route, distributed mainly on the penumbra regions of the ischemic brain and lead to reduced infarct size and functional recovery. 110\n3.2. Polymer-based nanocarriers\nPolymeric nanocarriers (PNCs) are prepared from biocompatible and biodegradable polymers to dissolve (for nanospheres), entrap/encapsulate (for nanocapsule) or attach drugs to their matrix. 125 Different types of cargos including drugs, proteins and genes can be loaded onto the polymer nanocarriers to safely and specifically deliver to the target organ or tissue. Regarding their structural flexibility, functional groups and stability, PNCs are divided to the following categories: polymeric micelles (PM), polymeric nanocapsules (PNCPs), polymeric nanogels (PNGs), dendrimers (DDs), and hybrid nanoparticles with porous core (HNPCs). In recent years, various groups have reported targeted delivery based on ROS-responsive functional groups/or linkers such as boronic acid, sulfide, thioether and thioketal groups (figure 7b). The incorporation of these functional moieties in the polymeric backbone results in controlled release of drug in response to ROS. The mechanism of action for boronates as sensitive linkers relies on the oxidation-triggered hydrolysis of the boronic ester to a phenol and subsequently the nanoparticle degradation. Likewise, the mechanism of sulfide groups is based on the oxidative conversion of the hydrophobic sulfide moieties to the more-hydrophilic sulfoxides and sulfones 101 . On the\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nother hand, Gas-generating polymer nanoparticles are other novel carrier for targeted triggered drug release the sites of ROS stress. The internal pressure of the polymeric nanostructures increases in response to oxidative stress because H2O2 diffuses into the polymeric nanoparticle and generate gas owing to its interaction with other component. For instance, Sung et al. prepared a ROS-responsive hollow microsphere (HM) carrier including an anti-inflammatory drug, an acid precursor consisting of ethanol and FeCl2, and sodium bicarbonate (SBC) as a bubble generating agent. Low concentration of H2O2 could diffuse into HM and oxidize their encapsulated ethanol in the presence of Fe 2+ by the Fenton reaction to cause acidic condition which, in turn, resulted in decomposition of SBC to CO2 bubbles and subsequent release of drug (figure 7c). 126\nIn addition, polymer-drug and -protein conjugates are also widely used on cancer treatment which could also be exploited for I/R injury treatments.127\nFigure 7. a) Different types of active-targeting (stimuli-responsive) nanocarries. Adopted from ref.\n128 b) various ROS-responsive functional groups for the design of ROS-responsive nanocarrier\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nsystems. Adopted from ref.129 c) The mechanism of the ultrasensitive ROS-responsive gas-\ngenerating hollow microsphere for drug release in the site of ROS stress. Adopted from ref. 126"
    }, {
      "heading" : "3.1.1. Polymer-drug or polymer-protein conjugates",
      "text" : "The reduced toxicity and improved efficacy in clinical applications of the covalently bonded\npolymer-drug or -protein conjugates including PEGylated enzymes or cytokines and polymer-\nbound chemotherapy drugs, have already offered the opportunities for the treatment of ischemia-\ninduced oxidative stress. For instance, engineered polymer-drug conjugate (Poly-l-glutamic acid\n(PGA)-inhibitors of apoptotic protease activating factor 1 (Apaf-1)) limited hypoxia induced\napoptosis. 130 Polyethylene glycol (PEG)-nitric oxide (NO) conjugates improved endothelial\ndysfunction and reduced vasoconstriction after cheek pouch I/R injury in hamsters. 131 Owing to\ntheir outstanding properties such as super high capacity of drug loading, high degree of\nhomogeneity, reduced burst release, multivalency, improved pharmacokinetics relative to other\npolymeric nanoparticles with physically encapsulate drugs, predictable conformations in solution\nand the possibility to use various stimuli-responsive linkers for the design smart polymer–drug\nconjugates, polymer-drug or polymer-protein conjugates have aroused much attention for\ntargeted drug delivery to the sites of ROS stress. The peptide, ester and amide linkers are\ncommonly used in polymer–drug conjugates and can be hydrolytically and/or enzymatically\nbroken in the sites of ischemia.132, 133 Moreover, the use of the pH-responsive chemical bonds\nsuch as hydrazone and cis-acotinyl into structure of polymer-drug conjugates result in controlled\nrelease of drug under mild acidic condition in ischemic regions and cancer. 134 Some examples of\nsmart conjugated polymer-drugs have been summarized in Table 3.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A"
    }, {
      "heading" : "3.1.2. Polymeric micelles",
      "text" : "Polymer micelles are provided from amphiphilic block or graft copolymers in the aqueous\nsolution. The hydrophobic core of the polymeric micelles makes them a suitable carrier for\npoorly water-soluble drugs. 135 Biocompatibility, longer circulation time and higher capacity for\nloading drugs are considered as advantages of polymeric micelles. Polymeric micelles can be\nused as carriers for antioxidant drugs or be functionalized for sensing pH and ROS to target the\nischemic organ for drug delivery. 136 Free radical scavenger agents which are not soluble in the\nnormal pH could also be incorporated into the polymer micelles to increase their circulation time\nand efficacy. 137 Incorporation into the hydrophobic core of the polymeric micelles also prevented\nfrom disintegration of nitroxyl radicals, ROS scavenger, in lower pH of the ischemic tissue. 138\nThe some examples of smart polymeric micelles have been mentioned in Table 3."
    }, {
      "heading" : "3.2.3. Polymeric nanocapsules",
      "text" : "Polymeric nanocapsules (PNCPs), with an aqueous core surrounded by a hydrophobic domain,\nare exhibit potential for delivery of therapeutic agent into the ischemic tissue. 139 Owing to\nchangeability of physiochemical properties of some block-copolymers in the presence of\nbiologically relevant stimulus(pH, temperature) and external energy source (magnetic field,\nlight), PNCPs can be applied as excellent smart nanoreactors or artificial organelles to treat\nischemia regions(figure 8 a). 140 For instance, integration of a pH sensitive monomer in the\nhydrophobic block lead to formation of smart PNCPs. Sensitive monomer becomes hydrophilic\nand releases drug in response to pH changes in the sites of ischemia/ROS stress. 141 The some\nexamples of smart polymeric nanocapsules have been mentioned in Table 3.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nMoreover, the PNCPs provided from PLGA were used for encapsulating insoluble antioxidant\nflavonoid quercetin (QC) to improve its BBB penetration. The PLGA-QC nanocapsules were\nsuccessfully delivered to the ischemic brain and decreased mitochondrial damage, expression of\niNOS and proapoptotic proteins in young and aged rats, while QC by itself could not protect\nbrain I/R-injury. 142"
    }, {
      "heading" : "3.2.4. Polymeric nanogels",
      "text" : "Polymeric nanogels are self-assembled amphiphilic copolymers locked by different cross-\nlinking methods. 143 Polymeric nanogels are water soluble and biocompatible materials with\nstable encapsulation properties.144 Polymeric nanogels have been exploited for sustained and\nlong-term delivery of protective agents to the ischemic tissue. For instance, ultrapure alginate\nhydrogels were used for dual delivery of angiogenic VEGF and myogenic insulin-like growth\nfactor 1 (IGF1) to the ischemic muscle after limb I/R injury. Encapsulation in biodegradable\npolymer hydrogels leads to more functional recovery, sustained and localized release of\nVEGF/IGF1 to the ischemic regions. 145\nNegatively charged heparin nanogels encapsulated basic fibroblast growth factor (bFGF) and\nwere coated with polyethylenimine (PEI) on the surface to complex it with pDNA coding the\nVEGF165 (Figure ). This complex promoted endothelial progenitor cells differentiation to the\nmature endothelial cells which finally lead to neovascularization in hind limb model of\nischemia. 146 Due to the shielding effect of heparin, its conjugation with PEI improved in vivo\ngene transfection efficacy of PEI. Same to the polymeric micelles, the polymeric nanogles can\nbe self-assembled from “smart” block-copolymers to form stimuli‐responsive nanogels for drug\ndelivery and cell imaging. 147 For instance, Urokinase, a thrombolytic agent which has already\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nbeen used in clinic, was conjugated to a pH-sensitive PEG-nanogel and administered after\ncerebral I/R to decrease BBB leakage and mitochondrial damage at acute phase of ischemia. 148\nThe some examples of smart polymeric nanogels have been mentioned in Table 3.\nFigure 8. a) the use of “smart” block-copolymers into structure of PNCPs confer controlled release of drug in the\nsite of ROS stress in response to biologically relevant stimulus(pH, temperature) and external energy source\n(magnetic field, light). Adopted from ref. 140 b) Self-assembling heparin nanogels encapsulated basic fibroblast\ngrowth factor (bFGF) and complexed with pDNA using cationic poly(ethyleneimine) (PEI) polymers. Adopted\nfrom ref. 146\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n3.1.3. Dendrimers\nDendrimers are hyperbranched tree-like polymers with high density of functional groups on their\nsurface and small molecular volume, which are also considered as monomolecular polymer\nmicelles. Dendrimers comprised of three parts: single atom or atomic groups in center, repeating\nunits forming several interior layers and multiple functional groups located at surface.\nDepending on the amphiphilic property and interior cavities, dendrimers can be applied for\nencapsulating hydrophobic and hydrophilic drugs. 149 It has been shown that injected dendrimers\nare automatically and selectively taken up by ischemic and traumatic brain regions. 150\nDendrimers, such as poly (amido amine) (PAMAM), can be linked to drugs or therapeutic\nmolecules to deliver them with higher concentrations to the ischemic region or within the\nischemic cells and increase their circulation time.151, 152 In addition to the ischemic organ,\ndendrimers can target the inflammatory cells including activated macrophages and microglia\ncells. 150 In addition to drug delivery, some studies have used dendrimers for gene delivery to the\nvarious ischemic organs and through different administration routes.153 For example, the\nPAMAM dendrimer coupled with arginine-grafted poly (disulfide amine) (ABP) (PAM-ABP)\nwas applied in delivering the plasmid DNA with hypoxia response element (HR1) to the\nischemic heart. The PAM-ABP improved cellular uptake of the HR1 and increased its retention\non the extracellular matrix. 154 On the other hand, stimuli-responsive dendrimers or smart\ndendrimers have been found to be promising candidates as carriers to treat ischemia areas\nbecause they release payloads at targeted sites or at constant release profiles in response to a\nspecific trigger. In the case of acid-responsive dendrimers, drug conjugates to dendrimer via\nacid-labile bonds such as hydrazine linkage and the boronate ester bonds. Acid-responsive\ndendrimers are stable at pH 7.4, but are cleavable in acidic milieu or in the sites of ROS stress.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nMoreover, some drugs such as N-Acetyl cysteine (NAC), an antioxidant and an anti-\ninflammatory agent, can be conjugate to dendrimers via reduction-labile bonds containing\ndisulfide bond to form reduction-responsive dendrimers. The abundant intracellular GSH triggers\ndrug release of reduction-responsive dendrimers in ischemic regions(figure 9a). 155 Enzyme-\nresponsive dendrimers are other types of smart dendrimers that contribute to controlled drug\nrelease in the site of ROS stress. For instance, Wiwattanapatapee et al. prepared an enzyme-\nresponsive dendrimer containing 5-aminosalicylic acid drug via an azo-containing linker to\ninhibit inflammation in colon. Nanocarrier was stable in stomach and small intestine while\nstrongly released drug in colon owing to the presence of azoreductase(figure 9 b). 156 The some\nexamples of smart dendrimers have been mentioned in Table 3.\nFigure9. a) The reduction-responsive dendrimer and b) the enzyme-responsive dendrimer. Adopted from ref. 157\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A"
    }, {
      "heading" : "4. Nanoparticles as imaging and diagnostic tools",
      "text" : "Beside their therapeutic and delivery applications, nanomaterials can also be exploited as\nmolecular probes for different imaging modalities to determine the location and diagnose disease\nprocess. 158-160 To visualize, monitor or record spatiotemporal distribution of molecular and\ncellular processes, imaging modalities such as optical imaging (luminescence and fluorescence),\nradionucleotide-based imaging [positron emission tomography (PET), single photon emission\ncomputed tomography (SPECT)], magnetic resonance imaging (MRI), computed tomography\n(CT) and ultrasound need specific molecular probes to target molecules, cells or tissues and\nallow them to be imaged. 161 In general, imaging probes consists of three elements signal agent,\ntarget and linker which has been summarized in (Figure 10a). A desired molecular imaging\nprobe should provide high binding affinity and specificity to target, high sensitivity and high\nstability in vivo as well as less toxicity. Macrophages are one of the pivotal components in\nmediating tissue damage in the sites of ROS stress and ischemic regions. Owing to their short\nlifetime and nanomolar or lower range of H2O2 level (an important endogenous ROS in\nmacrophages), smart and high sensitive probes containing H2O2-reactive moieties are essential\nfor real-time imaging and the visualization of H2O2 in macrophages. 162\nCompared to the protein imaging markers, nanoparticles with the same size are highly flexible\nto the modifications and therefore provide versatile platforms for engineering multimodal and\nmultifunctional imaging agents for in vivo imaging. 163 For instance, a typical antibody loses its\nantigen-recognition functionality after 10 substitutions, while nanoparticle of the same size can\nbare 1500 modification sites. 164\nNanoparticles can improve signal quality in less-sensitive imaging techniques (CT and MRI) by\nencapsulating large payloads of contrast materials and target delivery of them into the desired\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\ntissue. 165 The major nanomaterials which are used as diagnostic/theranostic agents in I/R injury\nmodels of different organs or in stroke models are micelles, liposomes, polymer nanoparticles,\ndendrimers, lipoprotein nanoparticles, nanoemulsions and metal NPs (figure 10 b).\nFigure 10. a) Examples of three typical components of molecular imaging probes. SPION:\nSuperparamagnetic iron oxide, Gd: Gadolinium, NIRF: Near infrared, BBB: blood brain barrier,\nROS: reactive oxygen species. Adopted from ref. 166 b) Schematic view of the most common\ndiagnostic and theranostic nanoparticles. Adopted from ref .167"
    }, {
      "heading" : "4.1. Metal and metal-oxide nanoparticles",
      "text" : "4.1.1. Iron oxide nanoparticles (IONPs)\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nAmong the various NPs used in potential diagnostic applications, IONPs are the only one\nwhich has been successfully incorporated into the clinical applications.167 The IONPs with\nsuperparamagnetic property have extensively been applied as contrast agent for MRI because of\ntheir biocompatibility, high relaxivity, non-toxicity and nonimmunogenicity in biological\nsystems. 168 The superparamagnetic iron oxide (SPIONs) with size range of 20-25 nm shows\nrapid filliping rate in response to the applied magnetic field. 169 The SPIONs have diverse\ntherapeutic and diagnostic applications in cerebral ischemic disease and stroke, including their\nuse as contrast agent for affected regions of brain and BBB after ischemia or stroke, perfusion-\nweight MRI sequences for imaging vessels and regional blood flow after ischemia, and\ndegeneration as well as tracing implanted or inflammatory cells after injury. 170, 171 SPIONs, as\ncontrast agents on MRI, speed up the early diagnosis of ischemic lesions and assists on detecting\nthe infraction core and penumbra regions.172 Since the ultrasmall superparamagnetic iron oxide\n(USPIONs) are taken up by macrophages and inflammatory cells in the body, they can be used to\ntrace them, too. The USPION enhanced MRI was applied to determine the macrophage\ninfiltration after ischemic stroke in human subjects. 173 Comparing the USPION-induced MRI\nsignal alterations and distribution of the iron-laden macrophages on the histological studies of\nthe same brain section in the animal models proved the visualization of the macrophage\ninfiltration into the ischemic region by USPION-enhanced MRI.174 The SPION-enhanced MRI\noffers a non-invasive method for long-term follow up of inflammatory process and monitoring\nlong-term outcomes after ischemic stroke. 175 The SPION-enhanced MRI gives the possibility to\ntrace the systemic or locally transplanted stem cells into different brain regions. 176, 177 In a case\nstudy by Jozwiak et al., cord blood-derived neural progenitor cells were labeled with SPIONs\nand transplanted into the intracerebroventricular areas of 16-month old child suffering from\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nglobal brain ischemia due to cardiac arrest. The MRI traced the fate of the implanted neural\nprogenitor cells. 178"
    }, {
      "heading" : "4.1.2. Gold nanoparticles",
      "text" : "The GNPs have many subtypes with various physical properties due to their size and shapes\n(including nanospheres, nanorods, nanoshells and nanocages). Several advantages of GNPs over\nliposomes and polymer micelles are flexibility to be fabricated in narrow range of sizes,\nnanoparticle surface energy transfer (NEST) and fuorescence quenching. 179 Beside their intrinsic\nantioxidant and anti-apoptotic properties, GNPs can be used as carriers for drugs or imaging\nagents to the ischemic regions. High molecular weight fluorescein-hyaluronic acid (HA)\nconjugated to GNPs are degraded in the presence of ROS and emits strong flurescence-recovery\nsignals which are applied for designing ROS-sensitive Au nanoprobes and imaging ROS levels\nin ischemic cells or tissue. The GNP-HAs are fluorescence quenched in non-ROS conditions,\ndue to the NEST, while emit strong fluorescence signals in the presence of ROS, due to the HA\ncleavage. 180 In an another report, GNP -HA injected locally to the brain before ischemia and\nnear infrared fluorescence signals were imaged 6 to 36 hours after ischemia in brain slices. The\nresults showed that ROS reaches to its peak at 24 hours after cerebral ischemia (figure 11) 179\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nFigure 11. GNP-HA ex vivo imaging of ROS in different times after brain ischemia. Adopted\nfrom ref. 179\nMyocardial scar thickness and size could be used as an index for myocardial viability after\ninfarction. GNPs were coated by collagen adhesive peptide (CNA35) to target the myocardial\nscars one month after ischemia reperfusion and imaged by CT. 181 Ex vivo images of the ischemic\ncore is also possible with surface-enhanced Raman spectroscopy (SERS) spectroscopy of gold\nnanostructures named gold nanocoral (GNC), which sensed the spatial distribution of ATP,\nADP, AMP, adenosine, inosine, hypoxanthine, and xanthine at acute phase of the cerebral\nischemia. 182 Another application of GNPs on diagnosis of the ischemia is in vivo cell tracking by\nmultiple imaging modalities. 183 Depending on the physicochemical properties of gold\nnanoparticles such as shape, size and surface chemistry, their absorption characteristics can be\ntuned to maximally absorb in the near infrared region. Owing to surface plasmon resonance, they\ndisplay superior optical absorption properties as excellent photoacoustic contrast agents.\nSurprisingly, different shapes of gold nanoparticles can be used to distinguish visualization both\ndelivered stem cells and macrophages in ischemic areas because of different their maximal\nabsorption( gold nanorods in the near-infrared region, gold nanospheres in the visible light\nregion (520 nm) and endocytosed gold nanospheres by macrophages in optical window of 650–\n900 nm). 184\nCurrently, multi-photon luminescence of gold nanoparticles has been found to make them\nfascinating materials for molecular imaging of cerebral vasculature and BBB integrity under\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\npathological conditions because they exhibit long-term photostability, high biocompatibility and\nstrong multi-photon absorption cross-section. 185"
    }, {
      "heading" : "4.2. Micelles for diagnosis of I/R injury",
      "text" : "Beside the delivery of the therapeutic agents by polymeric micelles, surfactant micelles, PEG-\nmicelles, lipid-base micelles and targeted micelles can also be applied in imaging and diagnostic\npurposes. 186 In the ischemic organ, the leaky vascular system enhances the permeability and\nretention rate (EPR) of micelles. 187 Therefore, micelles can be utilized to achieve higher\nconcentration of imaging reporters and deliver them to the ischemic region.\nVascular disruption and plasma leakage in acute and chronic inflamed tissues was imaged by\nfluorescence molecular tomography which detected the near-infrared (NIR) cyanine dye-doped\ninto aqueous micelles. 188 Moreover, Yokoyama et al. used a polymeric micelle magnetic\nresonance imaging (MRI) contrast agent (Gd-micelles) for visualization of hyper-permeability in\nthe BBB in cerebral ischemia-reperfusion injury. 187\nAs mentioned above for targeted drug delivery, stimuli-responsive polymeric micelles or\nsmart polymeric micelles can be used as nanocarrier for targeted delivery and controlled release\nof ultrasensitive probes to monitor ischemic areas. Recently, Lee et al. developed a pH-\nresponsive biodegradable polymeric micelle system based on typical ring opening\npolymerization of N-carboxyanhydrides (NCAs-ROP) using mPEG-NH2 as a macroinitiator for\nsynthesis of the mPEG-b-P(DPA-DE)LG copolymer and a sequential aminolysis reaction to\ngraft pH-sensitive ligands and two types of amine-terminated dopamine groups onto side chain.\nThe author mentioned that the dopamine groups facilitated self-assembly and subsequent\nenhanced long-term stability because of their high-affinity to iron oxide nanoparticles. In\nischemic tissue, changes in pH resulted in release of MRI probes and enhancement of negative\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\ncontrast with r2 relaxivity of approximately 106.7 mM -1 s -1 . 189 In a follow-up study by the same\ngroup, pH-responsive multiblock copolymer was applied as nanocarriers of CdSe@ZnS/ZnS\nQuantum Dots to form pH-triggerable targeting fluorescence imaging probes for targeted\ndiagnosis of acidic pathological regions. 190\nFigure 12. a) Schematic representation of the acidic pH-triggered Fe3O4-loaded mPEG-b-P(DPADE)LG micelles. b) T2-weighted MR imaging of focal cerebral ischemia enhanced by (A) Fe3O4loaded mPEG-b-P(DPA-DE)LG, (B) Fe3O4-loaded mPEG-b-P(DPA)LG as a control group, and (C) mPEGb-P(DPA-DE)LG copolymer. In the case of Fe3O4-loaded mPEG-b-P(DPA-DE)LG, the acidic milieu of ischemic region resulted in release of Fe3O4 nanoparticles (red circle). Adopted from ref. 189 c) Schematic representation of CdSe@ZnS/ZnS Quantum Dots Loaded in Polymeric Micelles and release of CdSe@ZnS/ZnS imaging probes under acidic condition. d) fluorescent image of CdSe@ZnS/ZnS Quantum Dots Loaded in Polymeric Micelles treated MACO rat group. Adopted from ref. 190 Jo\nur\nna lo\nfM\nat\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n4.3. Liposomes\nLiposomes, the same as micelles, are passively targeting the ischemic regions with slower\naccumulation rate (relating to their larger sizes (~100 nm) compared to micelles (~15 nm)).\nLiposomes can be used to deliver contrast agents to desired tissue in a controlled manner.\nLiposome - surface anchoring of contrast agents can retain their efficacy and subsequently\ndecrease their toxicity. 191 As a promising example, Kong et al. developed a liposome coated\nwith MRI contrast agents using chitosan conjugated with octadecyl chains and\ndiethylenetriaminepentaacetic acid (DTPA) as polymeric fastener which contributed to\nimmobilization of chelated gadolinium onto the surface of liposomes through electrostatic and\nhydrophobic assembly. The chitosan-coated, cross-linked liposomes improved their integrity and\ncontrolled delivery of gadolinium to ischemic site (figure 13a). 192\n4.3. Polymeric nanoparticles and dendrimers\nPolymeric NPs and dendrimers can be used for coating the imaging agents in order to increase\ntheir circulation time and mitigate their toxicity, resulting in better delivery into the target\nischemic region and so enhancing the recorded signals. 193, 194 Regarding the lower intrinsic\ncontrast of the kidney, application of polymer-based contrast agents enhances the MRI contrast.\nThe amino groups on the outer surface of the dendrimers can be conjugated with MRI contrast\nagents and be used for imaging. 195 Large dendrimers with lower renal excretion rate remains in\nthe circulation and are used for imaging vessels. Large hydrophobic dendrimers accumulate in\nspleen and liver can be used for imaging these two organs and small dendrimers with rapid\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nexcretion can be applied for kidney imaging. Contrast agents with larger dendrimers did not\naccumulate in renal tubules which are the main functional units in kidney and target of ischemic\ninjury. In the experimental acute renal failure, PAMAM-based dendrimer-based MRI contrast\nagents, with smaller dendrimer sizes, helped to non-invasively diagnose ischemia-induced\ntubular damage and renal injury before the serum creatinine is elevated. 196 A non-invasive\nimaging method to study angiogenesis is highly required for monitoring the probable effects of\nthe treatments on angiogenesis after ischemia. Almutairi et al. engineered a dendrimer-based\nPET nanoprobe to target specifically angiogenesis after hind limb ischemia. Polyethylene oxide\n(PEO) chains formed protective shell for 76Br and in the surface conjugated with targeting\npeptides cyclic arginine-glycine-aspartic acid (RGD) to target αVβ3 integrin receptor which is\nhighly expressed in the areas of angiogenesis. The probe improved bioavailability of 76Br, its\nbinding and specificity to the tissue with higher αVβ3 integrin expression. 197 Understanding the\npathological signals such changes in pH, oxygen levels, hypoxia and the cellular oxidative state\nare of utmost importance for design of smart polymeric nanoparticles and further development of\nmolecular imaging because of their close association with oxidative stress related disease and\ncancer. 198 As a promising example of smart polymeric nanoparticles in molecular imaging, Sung\net al. prepared a dual-responsive nanoparticle system containing Cy3 dye, encapsulated\ncurcumin (as anti-inflammatory agent), a hydrophobic copolymer poly-(1,4-phenyleneactone\ndimethylene thioketal)(PPADT) (as a pH-responsive and oxidative stress responsive group)\nbased on interaction between both hydrophobic moieties and N-palmitoyl groups of Cy3 dye and\nthe amine groups of backbone of the chitosan polymer. The hydrophobic interactions led to self-\nassembly of the nanoparticles at pH 7.4. The smart polymeric nanoparticle system was degraded\ninto PPADT hydrophilic components in the acidic milieu produced by activated macrophages\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nand released the payload drug, that was monitored by FRET and confocal laser scanning\nmicroscopy (CLSM) imaging(figure 13b). 199 Moreover, in accordance to the recent studies,\npolyoxalate nanoparticles were functionalized for imaging oxidative conditions such as H2O2\nconcentration and apoptosis in the ischemic tissue. Ploy vanillin oxalate (PVO), a polymeric\nvanillin, scavenges H2O2 and provides CO2 bubbles. Kang et al., used these properties of PVO to\nprovide CO2 bubbles in the ischemic regions of the liver which contains higher H2O2 and\nprovides strong echogenic reflectivity in the ultrasound field (figure 13c). 200\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nFigure13. a) Schematic representation of liposomes loaded with gadolinium by a polymeric\nfastener. Adopted from ref. 192 b) Nanoparticles with dual responses to oxidative stress and\nreduced pH for molecular imaging and treatment of inflammation and ischemic regions.\nAdopted from ref. 199\nc) Theranostic PVO for H2O2 scavenging and imaging the H2O2\nconcentrated, ischemic, areas by CO2 bubble formation and ultrasound. Adopted from ref. 96"
    }, {
      "heading" : "4.4. Toxicity of nanomaterials",
      "text" : "Besides the several advantages which nanoparticles offering as antioxidant drugs or nanocarriers,\nthe potential citotoxicity induced by them should be considered carefully. However, the focus of\nthe present study is not on the toxicities induced by nanoparticles. The toxicity can be related to\nROS generations and inflammatory reactions. Below we included few examples of potential\ncitotoxic properties:\nIt has ave been reported that CeONPs can cause an inflammatory response in vivo via pro-\ninflammatory cytokines production that largely depends on mast cell activation, and exacerbated\nmyocardial I/R injury. 201 Pan et al., reported that Au NPs with diameter of 1.4 nm can induce\nmitochondrial damage and release free radicals which causes cellular necrosis. 202 Many studies\nshow that Ag NPs can lead to oxidative stress, genotoxicity and apoptosis in cultured cells or\ntissue. 203-207 The known mechanisms for Ag NPs induced cellular toxicity include massive ROS\nproduction, depletion of antioxidant glutathione, increased caspase-3 activity and intracellular\ncalcium, as well as DNA damage. 208, 209 Fullerenes C60 which have been frequently reported as\nantioxidant agenst, can paradoxically act as both oxidants and antioxidants. Wingard et al.\nreported that C60 fullerene increases cardiac I/R injury, and coronary artery contraction in\nspraguedawley rats. 69, 210 Lai reported that polyhydroxylated fullerene derivatives C60(OH)72 at\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nhigh concentrations leads to the cellular apoptosis or necrosis, while at low concentrations\nprotect against oxidative stress after lung I/R injury. 211 MWCNTs increases ROS generation and\ndecreases activity of antioxidant enzymes like CAT and glutathione reductase (GR) through\nactivation of extracellular signal-regulated kinase (ERK) and mitogen-activated protein kinase\n(MAPK) signaling pathway. 212, 213 Despite the acute oxidative effect of PEGylated single-wall\nCNTs (SWCNT-PEG) on rat hippocampus, its long-term effect, one week after injection,\nappeared by increased expression of the genes for antioxidant enzymes, improved antioxidant\ndefense and reduced ROS production. 92 The general mechanisms by which CNTs lead to cell\ntoxicity has been summarized on the review by Schedova et al. 94 Concerning graphene as one of\nthe most promising biocompatible nanomaterials with carbon-based structure (carbon can be\nconsidered as the most compatible structure with organisms and tissues), nearly all reports\nincluding cell growths on surfaces of graphene sheets indicated its biocompatibility. 75, 214\nHowever, there are some other investigations regarding the size and concentration-dependent\ncyto- and geno-toxicities of graphene against stem cells, bacteria, spermatozoa and even\nanimals. 215, 216 Nanoscale graphene sheets (including graphene nanoplatelets and nanoribbons) at\nhigh concentrations (typically >100 µg/mL) could induce significant toxicities, resulting in, e.g.,\ncell death, DNA fragmentations and/or chromosomal aberrations of alive cells and disturbance in\nanimal hormone secretions. Hence, further investigations are highly required to better understand\nand then minimize the mechanisms involved in toxicity of nanomaterials (even carbon-based\nones). Until this moment, the following mechanisms have been established for describing the\npotential toxicity of graphene: 1) physical interaction of ultra-sharp edges of graphene with cell\nmemberanes, 2) ROS generation, and 3) capturing cells by aggregating graphene sheets in a\nsuspension. 217, 218 Although, functionalization of graphene and protein corona effect can decrease\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nthe toxic effects, these mechanisms may still be occurred in diagnosis and treatments followed\nby graphene release in body and hence should be studied with more details to control the\npotential risks in upcoming medical purposes. 219 The findings mentioned above seem to have\ncontroversy with protective effects of nanomaterials in coping with oxidative stress and IR\ninjury. For these controversial results, a number of groups including our group have reported that\nbiological behavior and the toxicity of nanomaterials strongly is associated with their\nfabrication methods and the physicochemical properties such as structure, surface chemistry,\nsize, charge and functional groups. 220, 221 It was found that the toxicity of nanomaterials can be\ncontrolled by their surface chemistry and synthetic methods. 222, 223"
    }, {
      "heading" : "4.5. Bloodstream circulation and clearance patterns of nanomaterials",
      "text" : "Circulation features and clearance patterns of nanomaterials have been singled out for great\nhealth concern since their toxic effects have not been known completely. Various factors\nincluding the surface charge, size, shape, surface-to-volume ratio and functionalized groups\ninfluence the bloodstream circulation and organ clearance. Moreover, they can affect protein\nadsorption, aggregation, agglomeration, surface reactivity and toxicity of nanomaterials. 103 High\nsurface energy of nanomaterial confers protein adsorption through the interfacial reactions which\nin turn resulted in protein corona formation around the nanoparticles. 224 Protein corona may\ninfluence the blood circulation half-life of nanomaterial. 225 Composition of the protein corona\ncan determine the blood circulation, biodistribution, clearance profiles and fate of nanomaterials\nin body. 226 Opsonin protein absorbtion may enhance clearance of nanomaterial by RES\nmacrophages through rapid uptake into the liver and the spleen tissues. Functionalization of\nnanomaterial by poly (ethylene glycol) (PEG) can decrease absorption of opsonin proteins via\nsteric repulsion that increase their blood circulation and retention time. Protein corona may\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nhamper targeting of nanomaterial to desired tissues via lose their targeting capabilities. 227 On\nother hand, absorbtion of certain apolipoproteins to particle surface can improve across the blood\nbrain barrier (BBB) into the brain or to desired tissues. 228 Moreover, protein corona may prevent\ncell damage and decrease cell uptake in various tissues via reduction unspecific and strong\ninteractions of nanomaterial with the cell membranes. 229 A recent study has been shown that\nprotein corona can guard against ROS-induced toxicity in human macrophages via inhibition of\nmitochondrial damage and inflammation by Fe3O4-PEG nanoparticles. 230 Beside protein\nabsorption, different factors such as size, shape and surface chemistry may influence the location\nand biodistribution of nanomaterials. Kupffer cells of the liver, the spleen macrophages and the\nreticuloendothelial system (RES) play an important role in rapid clearance nanomaterial of blood\ncirculation, thereby high dose of them may cause hepatotoxicity and spleen damage. Degradation\nand metabolism of many nanomaterials such as Polymer-based nanostructures and\nsuperparamagnetic iron oxide have been identified that decrease their toxicity whereas other\nnanomaterial such as fullerenes, QDs and silica NPs did not degrade in vivo. 231 The degradability\nof carbon-based materials (especially graphene) is highly desirable in various bio-applications,\nsince graphene showed some potentials for degradation under UV and NIR irradiations.216, 232\nInert nanomaterials may metabolize by many enzymes. In addition, the body may eliminate\nnanomaterials via exhaled breath, the biliary duct, saliva, seminal fluids and the kidneys. 233"
    }, {
      "heading" : "5. Conclusion and future perspective",
      "text" : "Numerous attempts by many groups around the world have been made to improve the design\nof new materials and devices for treatment and diagnosis of IR injury because it is leading\ncause of seriously debilitating diseases such as ischemic stroke and myocardial infarction.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nUnfortunately, numerous protective drugs and contrast agents have failed to show benefit in\nthe diagnosis and the treatment of ischemic regions and the sites of ROS stress. Targeted\ndelivery, controlled release of drug and contrast agents and enhanced specificity of targeted\nimaging remains the main challenge to improve quality of life and clinical outcomes in of\npatients with ischemic stroke and myocardial infarction, because of the toxicity, short blood\ncirculation time, fast metabolization, poor diffusion across the blood–brain barrier (BBB),\nblood-testis barrier and blood–spinal cord barrier (BSCB), poor solubility and serious side\neffects of most antioxidant drugs and contrast agents. On the other hand, effective treatment\nof these serious debilitating disorders has been often challenged by concerns regarding great\ndegree of their complexity and the mechanisms involved in human. Nanomaterials for\ntargeted therapy and visualization, as well as “payload” release in desired tissue have\nattracted widespread attention from the scientific community in recent years. Understanding\nthe biochemical changes in ischemic organs, smart material design (biodegradability and\nbiocompatibility), physicochemical properties (surface chemistry, size, charge, shape,\nfunctionality, molecular imaging probes) might overcome the barriers for future safe and\neffective molecular imaging and treatment of ischemic stroke and myocardial infarction.\nHow to conquer the realization of such eclectic approaches for routine clinical use is a\nchallenging task for our future research."
    }, {
      "heading" : "Acknowledgments",
      "text" : "Authors thank Dr. Axel Blau for his comments and editing the paper. OA would also like to\nthank the Research Council of Sharif University of Technology.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nTable 1. Direct antioxidant properties of nanoparticles and related cell/tissue/organ protection mechanism against I/R injury\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nTable 2. Two main categories of nanocarriers for drug delivery in clinical settings.\nNP type NP Antioxidant\nproperty\nCell/organ protection mechanisms against I/R Ref\nMetal\nCeONPs\n- ROS scavenging - RNS scavenging - Autocatalytic - ↓ Lipid peroxidation - ↓ ER stress-associated genes\n- ↓Pro-apoptotic proteins expression\n234, 235\nPtNs\n- ROS scavenging - CAT/SOD\nmimetic\n- ↓ MMP activity - ↓ Collagen IV\n41, 44\nGNPs\n- ROS and RNS\nscavenging\n- Enhancing\nantioxidant strength of other antioxidants\n- ↑ Anti-inflammatory cytokines\nexpression\n- ↑ Anti-apoptotic proteins expression - ↓ Pro-apoptotic proteins expression\n50, 236\nSeNPs\n- ROS\nscavenging\n- ↓ ROS\ngeneration\n- ↑ Antioxidant\ndefense\n- ↓ MDA levels\n- Maintain calcium homeostasis - ↓ Pro-apoptotic proteins expression - ↓ Neutrophil infiltration - ↑ Neuvascularization - ↓ DNA fragmentation - ↓ Preserve mitochondrial ATP\n- 56\nCarbonbased\nFullerene s\n- ↓ ROS\ngeneration\n- ROS scavenging - ↑ Antioxidant\ndefense\n- ↓ MDA levels\n- ↓ Pro-apoptotic proteins expression - ↓ Lipid peroxidation - - ↑ NO\n- ↓ Cellular immune response\n237, 238\nGraphene\n- ↓ ROS\ngeneration\n- ROS scavenging\n--\n86\nCNTs\n- ↓ ROS\ngeneration\n- ↑ Antioxidant\ndefense\n- Restoring cerebral blood flow - ↓ Lipid peroxidation\n239, 240\nPolymer -based\nHPOX - H2O2\nscavenging\n- ↓ Pro-inflammatory factors expression - ↑ eNOS - ↑ VEGF expression - ↑ Neovascularization - ↓ Pro-apoptotic proteins expression\n97\nPVAX - H2O2\nscavenging\n- ↓ Pro-inflammatory factors expression - ↓ Pro-apoptotic proteins expression\n241\nPVO - H2O2\nscavenging\n- ↓TNF-α activity - ↓ Pro-apoptotic proteins expression\n96\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nDrug delivery types\nCategory Types Ref\nPolymerbased\n- Polymer-protein\nconjugation\n- Polymer-drug\nconjugation\n- Polymeric micelles\n(PMs)\n- Polymeric\nnanocapsules (PNCPs) - Polymeric nanogels\n(PNGs)\n- Dendrimers (DDs) - Hybrid nanoparticles\nwith porous cores (HNPCs)\n- Hydrophobic drug loading\ncore and hydrophilic shell (poorly water soluble drugs) - Polymersomes (aquatic\ncore and amphiphilic copolymer shell) - Hydrophilic polymer\nnetworks with tendency to absorb water - Perfectly branched\nmacromolecules forming spherical polymers - Inorganic silica core\n(mesopore) coated with polymer shell\n242\nLipidbased\n- Nanoliposomes (NLs) - Solid lipid\nnanoparticles (SLNPs)\n- Nanostructured lipid\ncarriers (NLCs)\n- Amphipathic phospholipid\nenclosing an aqueous space - Lipospheres with solid\nlipid core\n- Matrix of solid- and\nliquid-phase lipids\n243, 244\nTable 3. Smart polymer-based nanocarriers for drug delivery to the ischemic organ\nPolymer-based nanocarriers\nStimuli Stimuli response part/linker Cargo\n(ligand)\nRef\nPolymer-drug conjugates\nH 2 O2\nphenylboronic ester Naproxen 132\nPolymeric micelles\npH\nacid-labile hydrazone chemical bond\nprednisolo ne 245\nPolymeric microsphere\nROS ROS\npoly(propylene sulfide)\npoly(propylene sulfide)\ncurcumin\n246 247\nPolymeric nanocapsules H2O2 the poly-(vinylferrocene) block Pyrene 248\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\nPolymeric nanogels\npH,\nfrequency ultrasound\nBenzaldehyde-terminated polyethylene glycol,\nbenzaldehyde-capped polyethylene oxide\nUrokinase\nurokinasetype plasminog en activator\n249\n250\nDendrimers glutathione disulfide linkages N-Acetyl\ncysteine 251\n1. D. J. Hausenloy and D. M. Yellon, Nature reviews. Cardiology, 2016, 13, 193. 2. M. Mahmoudi, M. Yu, V. Serpooshan, J. C. Wu, R. Langer, R. T. Lee, J. M. Karp and O. C. Farokhzad, Nature nanotechnology, 2017, 12, 845. 3. Á. Chamorro, U. Dirnagl, X. Urra and A. M. Planas, The Lancet Neurology, 2016, 15, 869-881. 4. G. Javedan, F. Shidfar, S. H. Davoodi, M. Ajami, F. Gorjipour, A. Sureda, S. M. Nabavi, M. Daglia and H. Pazoki-Toroudi, Molecular nutrition & food research, 2016, 60, 2665-2677. 5. C. Bright, R. Bright, E. Churchill, K. W. Leong and D. Mochly-Rosen, Journal, 2017. 6. C. Pac-Soo, H. Mathew and D. Ma, British journal of anaesthesia, 2014, 114, 204-216. 7. C. W. Evans, K. S. Iyer and L. C. Hool, Nanomedicine, 2016, 11, 817-832. 8. Y. Zhang, H. Zhang, Y. Wang, H. Wu, B. Zeng, Y. Zhang, Q. Tian and S. Yang, Journal of Materials Chemistry B, 2017, 5, 1846-1855. 9. M. R. Mohammadi, A. Nojoomi, M. Mozafari, A. Dubnika, M. Inayathullah and J. Rajadas, Journal of Materials Chemistry B, 2017. 10. M. H. Jazayeri, H. Amani, A. A. Pourfatollah, H. Pazoki-Toroudi and B. Sedighimoghaddam, Sensing and Bio-Sensing Research, 2016, 9, 17-22. 11. B. J. Thompson and P. T. Ronaldson, Advances in Pharmacology, 2014, 71, 165-202. 12. A. Gaudin, M. Yemisci, H. Eroglu, S. Lepetre-Mouelhi, O. F. Turkoglu, B. Dönmez-Demir, S. Caban, M. F. Sargon, S. Garcia-Argote and G. Pieters, Nature nanotechnology, 2014, 9, 1054-1062. 13. C. Saraiva, C. Praça, R. Ferreira, T. Santos, L. Ferreira and L. Bernardino, Journal of Controlled Release, 2016, 235, 34-47. 14. M. Leonor Pinzon-Daza, I. Campia, J. Kopecka, R. Garzón, D. Ghigo and C. Rigant, Current drug metabolism, 2013, 14, 625-640. 15. T.-T. Zhang, W. Li, G. Meng, P. Wang and W. Liao, Biomaterials science, 2016, 4, 219-229. 16. C. Tu, S. Das, A. B. Baker, J. Zoldan and L. J. Suggs, ACS nano, 2015, 9, 3436-3452. 17. S. Panagiotou and S. Saha, Frontiers in neuroscience, 2015, 9. 18. E. Birben, U. M. Sahiner, C. Sackesen, S. Erzurum and O. Kalayci, World Allergy Organization Journal, 2012, 5, 9. 19. M. Ajami, H. Pazoki-Toroudi, H. Amani, S. F. Nabavi, N. Braidy, R. A. Vacca, A. G. Atanasov, A. Mocan and S. M. Nabavi, Neuroscience & Biobehavioral Reviews, 2017, 73, 39-47. 20. H. Amani, M. Ajami, S. N. Maleki, H. Pazoki-Toroudi, M. Daglia, A. J. T. Sokeng, A. Di Lorenzo, S.\nF. Nabavi, K. P. Devi and S. M. Nabavi, Biochimie, 2017, 142, 63-79.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n21. H. Pazoki-Toroudi, H. Amani, M. Ajami, S. F. Nabavi, N. Braidy, P. D. Kasi and S. M. Nabavi, Ageing research reviews, 2016, 31, 55-66. 22. A. Karakoti, S. Singh, J. M. Dowding, S. Seal and W. T. Self, Chemical Society Reviews, 2010, 39, 4422-4432. 23. J. P. Saikia, S. Paul, B. K. Konwar and S. K. Samdarshi, Colloids and Surfaces B: Biointerfaces, 2010, 79, 521-523. 24. O. Akhavan, M. Kalaee, Z. Alavi, S. Ghiasi and A. Esfandiar, Carbon, 2012, 50, 3015-3025. 25. R. Sandhir, A. Yadav, A. Sunkaria and N. Singhal, Neurochemistry international, 2015, 89, 209- 226. 26. K. B. Narayanan and H. H. Park, Advances in colloid and interface science, 2013, 201, 30-42. 27. A. Y. Estevez, B. Stadler and J. S. Erlichman, The FASEB Journal, 2017, 31, 693.695-693.695. 28. N. P. Sardesai, D. Andreescu and S. Andreescu, Journal of the American Chemical Society, 2013, 135, 16770-16773. 29. C. K. Kim, T. Kim, I. Y. Choi, M. Soh, D. Kim, Y. J. Kim, H. Jang, H. S. Yang, J. Y. Kim and H. K. Park, Angewandte Chemie, 2012, 124, 11201-11205. 30. K. L. Heckman, W. DeCoteau, A. Estevez, K. J. Reed, W. Costanzo, D. Sanford, J. C. Leiter, J. Clauss, K. Knapp and C. Gomez, ACS nano, 2013, 7, 10582-10596. 31. J. Dowding, W. Song, K. Bossy, A. Karakoti, A. Kumar, A. Kim, B. Bossy, S. Seal, M. Ellisman and G. Perkins, Cell death and differentiation, 2014, 21, 1622. 32. M. Das, S. Patil, N. Bhargava, J.-F. Kang, L. M. Riedel, S. Seal and J. J. Hickman, Biomaterials, 2007, 28, 1918-1925. 33. J. M. Dowding, S. Seal and W. T. Self, Drug delivery and translational research, 2013, 3, 375-379. 34. F. Pagliari, C. Mandoli, G. Forte, E. Magnani, S. Pagliari, G. Nardone, S. Licoccia, M. Minieri, P. Di Nardo and E. Traversa, ACS nano, 2012, 6, 3767-3775. 35. Z. S. Bailey, E. Nilson, J. A. Bates, A. Oyalowo, K. S. Hockey, V. S. S. S. Sajja, C. Thorpe, H. Rogers, B. Dunn and A. S. Frey, Journal of neurotrauma, 2016. 36. E. O. Gubernatorova, X. Liu, A. Othman, W. T. Muraoka, E. P. Koroleva, S. Andreescu and A. V. Tumanov, Advanced Healthcare Materials, 2017. 37. A. Dhall, A. Burns, J. Dowding, S. Das, S. Seal and W. Self, Environmental Science: Nano, 2017, 4, 1742-1749. 38. K. M. Nash and S. Ahmed, Nanomedicine: Nanotechnology, Biology and Medicine, 2015, 11, 2033-2040. 39. M. Moglianetti, E. De Luca, D. Pedone, R. Marotta, T. Catelani, B. Sartori, H. Amenitsch, S. F. Retta and P. P. Pompa, Nanoscale, 2016, 8, 3739-3752. 40. T. Hamasaki, T. Kashiwagi, T. Imada, N. Nakamichi, S. Aramaki, K. Toh, S. Morisawa, H. Shimakoshi, Y. Hisaeda and S. Shirahata, Langmuir, 2008, 24, 7354-7364. 41. D. Pedone, M. Moglianetti, E. De Luca, G. Bardi and P. P. Pompa, Chemical Society Reviews, 2017, 46, 4951-4975. 42. H. Katsumi, K. Fukui, K. Sato, S. Maruyama, S. Yamashita, E. Mizumoto, K. Kusamori, M. Oyama, M. Sano and T. Sakane, Metallomics, 2014, 6, 1050-1056. 43. M. Takamiya, Y. Miyamoto, T. Yamashita, K. Deguchi, Y. Ohta, Y. Ikeda, T. Matsuura and K. Abe, Journal of neuroscience research, 2011, 89, 1125-1133. 44. M. Takamiya, Y. Miyamoto, T. Yamashita, K. Deguchi, Y. Ohta and K. Abe, Neuroscience, 2012, 221, 47-55. 45. M. Takamiya, Y. Miyamoto, T. Yamashita, K. Deguchi, Y. Ohta and K. Abe, Neuroscience, 2012, 221, 47-55. 46. C. Chen, S. Fan, C. Li, Y. Chong, X. Tian, J. Zheng, P. P. Fu, X. Jiang, W. G. Wamer and J.-j. Yin,\nJournal of Materials Chemistry B, 2016, 4, 7895-7901.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n47. M. Jazayeri, H. Amani, A. Pourfatollah, A. Avan, G. Ferns and H. Pazoki-Toroudi, Cancer gene therapy, 2016, 23, 365-369. 48. Z. Nie, K. J. Liu, C.-J. Zhong, L.-F. Wang, Y. Yang, Q. Tian and Y. Liu, Free Radical Biology and Medicine, 2007, 43, 1243-1254. 49. S. BarathManiKanth, K. Kalishwaralal, M. Sriram, S. R. K. Pandian, H.-s. Youn, S. Eom and S. Gurunathan, Journal of nanobiotechnology, 2010, 8, 16. 50. Z. Liu, Y. Shen, Y. Wu, Y. Yang, J. Wu, P. Zhou, X. Lu and Z. Guo, Journal of biomedical nanotechnology, 2013, 9, 1017-1028. 51. I. Somasuntharam, K. Yehl, S. L. Carroll, J. T. Maxwell, M. D. Martinez, P.-L. Che, M. E. Brown, K. Salaita and M. E. Davis, Biomaterials, 2016, 83, 12-22. 52. L. Yang, J. Sun, W. Xie, Y. Liu and J. Liu, Journal of Materials Chemistry B, 2017. 53. A. Bhattacharjee, A. Basu, T. Sen, J. Biswas and S. Bhattacharya, The Nucleus, 2017, 60, 137-145. 54. B. Huang, J. Zhang, J. Hou and C. Chen, Free Radical Biology and Medicine, 2003, 35, 805-813. 55. R. Soumya, V. Vineetha, P. S. Raj and K. Raghu, Metallomics, 2014, 6, 2134-2147. 56. K. Kalishwaralal, S. Jeyabharathi, K. Sundar and A. Muthukumaran, Journal of Trace Elements in Medicine and Biology, 2015, 32, 135-144. 57. W. Z. Teo, E. L. K. Chng, Z. Sofer and M. Pumera, Nanoscale, 2014, 6, 1173-1180. 58. R. M. Lucente-Schultz, V. C. Moore, A. D. Leonard, B. K. Price, D. V. Kosynkin, M. Lu, R. Partha, J. L. Conyers and J. M. Tour, Journal of the American Chemical Society, 2009, 131, 3934-3941. 59. Y. Qiu, Z. Wang, A. C. Owens, I. Kulaots, Y. Chen, A. B. Kane and R. H. Hurt, Nanoscale, 2014, 6, 11744-11755. 60. N. Martín, T. Da Ros and J.-F. Nierengarten, Journal of Materials Chemistry B, 2017, 5, 6425- 6427. 61. E. Castro, A. H. Garcia, G. Zavala and L. Echegoyen, Journal of Materials Chemistry B, 2017, 5, 6523-6535. 62. R. Bakry, R. M. Vallant, M. Najam-ul-Haq, M. Rainer, Z. Szabo, C. W. Huck and G. K. Bonn, International journal of nanomedicine, 2007, 2, 639. 63. A. Dellinger, Fullerenes and their potential in nanomedicine, The University of North Carolina at Greensboro, 2015. 64. F. Awan, E. Bulger, R. M. Berry and K. C. Tam, Cellulose, 2016, 23, 3589-3599. 65. J. J. Ryan, H. R. Bateman, A. Stover, G. Gomez, S. K. Norton, W. Zhao, L. B. Schwartz, R. Lenk and C. L. Kepley, The Journal of immunology, 2007, 179, 665-672. 66. B. U. Srđenović, M. N. Slavić, K. M. Stankov, N. V. Kladar, D. S. Jović, M. N. Seke and V. V. Bogdanović, Hemijska industrija, 2015, 69, 425-431. 67. S. Foley, C. Crowley, M. Smaihi, C. Bonfils, B. F. Erlanger, P. Seta and C. Larroque, Biochemical and biophysical research communications, 2002, 294, 116-119. 68. D. Monti, L. Moretti, S. Salvioli, E. Straface, W. Malorni, R. Pellicciari, G. Schettini, M. Bisaglia, C.\nPincelli and C. Fumelli, Biochemical and Biophysical Research Communications, 2000, 277, 711- 717.\n69. L. C. Thompson, R. N. Urankar, N. A. Holland, A. K. Vidanapathirana, J. E. Pitzer, L. Han, S. J. Sumner, A. H. Lewin, T. R. Fennell and R. M. Lust, Toxicological Sciences, 2014, 138, 365-378. 70. F.-Y. Hsieh, A. Zhilenkov, I. Voronov, E. Khakina, D. Mischenko, P. A. Troshin and S.-h. Hsu, ACS Applied Materials & Interfaces, 2017, 9, 11482-11492. 71. A. C. Neto, F. Guinea and N. M. Peres, Physics World, 2006, 19, 33. 72. O. Akhavan, M. Saadati and M. Jannesari, Nano letters, 2016, 16, 5619-5630. 73. O. C. Compton and S. T. Nguyen, small, 2010, 6, 711-723. 74. O. Akhavan, J Mater Chem B, 2016, 4, 3169-3190. 75. O. Akhavan and E. Ghaderi, Small, 2013, 9, 3593-3601.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n76. O. Akhavan, E. Ghaderi and R. Rahighi, ACS nano, 2012, 6, 2904-2916. 77. O. Akhavan, E. Ghaderi, R. Rahighi and M. Abdolahad, Carbon, 2014, 79, 654-663. 78. Y. Qiu, Z. Wang, A. C. E. Owens, I. Kulaots, Y. Chen, A. B. Kane and R. H. Hurt, Nanoscale, 2014, 6, 11744-11755. 79. A. Sun, L. Mu and X. Hu, ACS Applied Materials & Interfaces, 2017, 9, 12241-12252. 80. B. R. Bitner, D. C. Marcano, J. M. Berlin, R. H. Fabian, L. Cherian, J. C. Culver, M. E. Dickinson, C. S. Robertson, R. G. Pautler, T. A. Kent and J. M. Tour, ACS nano, 2012, 6, 8007-8014. 81. E. Hashemi, O. Akhavan, M. Shamsara, R. Rahighi, A. Esfandiar and A. R. Tayefeh, RSC Advances, 2014, 4, 27213-27223. 82. D. Suresh, M. P. Kumar, H. Nagabhushana and S. Sharma, Materials Letters, 2015, 151, 93-95. 83. V. Ruiz, L. Yate, I. García, G. Cabanero and H.-J. Grande, Carbon, 2017, 116, 366-374. 84. O. Akhavan and E. Ghaderi, Journal of Materials Chemistry B, 2013, 1, 6291-6301. 85. J. Park, B. Kim, J. Han, J. Oh, S. Park, S. Ryu, S. Jung, J.-Y. Shin, B. S. Lee and B. H. Hong, ACS nano, 2015, 9, 4987-4999. 86. Q. Song, Z. Jiang, N. Li, P. Liu, L. Liu, M. Tang and G. Cheng, Biomaterials, 2014, 35, 6930-6940. 87. O. Akhavan, E. Ghaderi, S. A. Shirazian and R. Rahighi, Carbon, 2016, 97, 71-77. 88. Z. Zhou, Z. Xu, F. Wang, Y. Lu, P. Yin, C. Jiang, Y. Liu, H. Li, X. Yu and Y. Sun, OncoTarget, 2016, 7, 71998. 89. M. F. De Volder, S. H. Tawfick, R. H. Baughman and A. J. Hart, science, 2013, 339, 535-539. 90. N. I. Krinsky, Annual review of nutrition, 1993, 13, 561-587. 91. P. Watts, P. Fearon, W. Hsu, N. Billingham, H. Kroto and D. Walton, Journal of Materials Chemistry, 2003, 13, 491-495. 92. L. Dal Bosco, G. E. Weber, G. M. Parfitt, A. P. Cordeiro, S. K. Sahoo, C. Fantini, M. C. Klosterhoff, L. A. Romano, C. A. Furtado, A. P. Santos, J. M. Monserrat and D. M. Barros, PloS one, 2015, 10. 93. A. Galano, Nanoscale, 2010, 2, 373-380. 94. A. A. Shvedova, A. Pietroiusti, B. Fadeel and V. E. Kagan, Toxicology and applied pharmacology, 2012, 261, 121-133. 95. N. Kamaly, B. Yameen, J. Wu and O. C. Farokhzad, Chem. Rev, 2016, 116, 2602-2663. 96. C. Kang, W. Cho, M. Park, J. Kim, S. Park, D. Shin, C. Song and D. Lee, Biomaterials, 2016, 85, 195- 203. 97. B.-R. Cho, D. R. Ryu, K.-S. Lee, D.-K. Lee, S. Bae, D. G. Kang, Q. Ke, S. S. Singh, K.-S. Ha and Y.-G. Kwon, Biomaterials, 2015, 53, 679-687. 98. X. Liu, Y. Yang and M. W. Urban, Macromolecular Rapid Communications, 2017. 99. Q. Xu, C. He, C. Xiao and X. Chen, Macromolecular bioscience, 2016, 16, 635-646. 100. R. Fang, H. Xu, W. Cao, L. Yang and X. Zhang, Polymer Chemistry, 2015, 6, 2817-2821. 101. C. Tapeinos and A. Pandit, Advanced Materials, 2016, 28, 5553-5585. 102. D. Lee, S. Bae, Q. Ke, J. Lee, B. Song, S. A. Karumanchi, G. Khang, H. S. Choi and P. M. Kang, Journal of controlled release, 2013, 172, 1102-1110. 103. D. Lee, S. Bae, D. Hong, H. Lim, J. H. Yoon, O. Hwang, S. Park, Q. Ke, G. Khang and P. M. Kang, Sci Rep-Uk, 2013, 3. 104. J. Kwon, J. Kim, S. Park, G. Khang, P. M. Kang and D. Lee, Biomacromolecules, 2013, 14, 1618- 1626. 105. C. Tang, D. Amin, P. B. Messersmith, J. E. Anthony and R. K. Prud’homme, Langmuir, 2015, 31, 3612-3620. 106. W. Cao, Y. Gu, T. Li and H. Xu, Chemical Communications, 2015, 51, 7069-7071. 107. K. Ulbrich, K. i. Holá, V. Šubr, A. Bakandritsos, J. Tucek and R. Zboril, Chemical reviews, 2016,\n116, 5338-5431.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n108. D. Eckmann, R. Composto, A. Tsourkas and V. Muzykantov, Journal of Materials Chemistry B, 2014, 2, 8085-8097. 109. Q. Han, X. Jia, Y. Qian, Z. Wang, S. Yang, Y. Jia, W. Wang and Z. Hu, Journal of Materials Chemistry B, 2016, 4, 7087-7091. 110. Y.-Z. Zhao, M. Lin, Q. Lin, W. Yang, X.-C. Yu, F.-R. Tian, K.-L. Mao, J.-J. Yang, C.-T. Lu and H. L. Wong, Journal of Controlled Release, 2016, 224, 165-175. 111. S. Liu, S. R. Levine and H. R. Winn, Journal of experimental stroke & translational medicine, 2011, 4, 16-23. 112. S. Liu, S. R. Levine and H. R. Winn, Journal of experimental stroke & translational medicine, 2011, 4, 16. 113. S. r. Draffehn and M. U. Kumke, Molecular pharmaceutics, 2016, 13, 1608-1617. 114. C. Chen, Z. Duan, Y. Yuan, R. Li, L. Pang, J. Liang, X. Xu and J. Wang, ACS Applied Materials & Interfaces, 2017, 9, 5864-5873. 115. Z. Wang, Y. Zhao, Y. Jiang, W. Lv, L. Wu, B. Wang, L. Lv, Q. Xu and H. Xin, Scientific reports, 2015, 5. 116. Y.-m. Lu, J.-y. Huang, H. Wang, X.-f. Lou, M.-h. Liao, L.-j. Hong, R.-r. Tao, M. M. Ahmed, C.-l. Shan and X.-l. Wang, Biomaterials, 2014, 35, 530-537. 117. S. Yajima, S. Miyagawa, S. Fukushima, Y. Sakai, A. Harada, H. Iseoka, M. Shiozaki, Y. Mori, Y. Yoshioka and Y. Sawa, Journal, 2016. 118. M. J. Lipinski, M. T. Albelda, J. C. Frias, S. A. Anderson, D. Luger, P. C. Westman, R. O. Escarcega,\nD. G. Hellinga, R. Waksman and A. E. Arai, Cardiovascular Revascularization Medicine, 2016, 17, 106-112.\n119. V. J. Caride and B. L. Zaret, Science, 1977, 198, 735-738. 120. W. C. Hartner, D. D. Verma, T. S. Levchenko, E. A. Bernstein and V. P. Torchilin, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2009, 1, 530-539. 121. T. Dvir, M. Bauer, A. Schroeder, J. H. Tsui, D. G. Anderson, R. Langer, R. Liao and D. S. Kohane, Nano letters, 2011, 11, 4411-4414. 122. N. M. Morsi, D. M. Ghorab and H. A. Badie, Pharmaceutical development and technology, 2013, 18, 736-744. 123. M.-e. Tan, C.-h. He, W. Jiang, C. Zeng, N. Yu, W. Huang, Z.-g. Gao and J.-g. Xing, International journal of nanomedicine, 2017, 12, 3253. 124. Z. Liu, L. Zhang, Q. He, X. Liu, O. C. Ikechukwu, L. Tong, L. Guo, H. Yang, Q. Zhang and H. Zhao, International journal of pharmaceutics, 2015, 489, 131-138. 125. F. Masood, Materials Science and Engineering: C, 2016, 60, 569-578. 126. M.-F. Chung, W.-T. Chia, W.-L. Wan, Y.-J. Lin and H.-W. Sung, Journal of the American Chemical Society, 2015, 137, 12462-12465. 127. C. J. Cheng, G. T. Tietjen, J. K. Saucier-Sawyer and W. M. Saltzman, Nature reviews. Drug discovery, 2015, 14, 239. 128. S. Ganta, H. Devalapally, A. Shahiwala and M. Amiji, Journal of controlled release : official journal of the Controlled Release Society, 2008, 126, 187-204. 129. G. Saravanakumar, J. Kim and W. J. Kim, Advanced Science, 2017, 4. 130. L. Mondragon, M. Orzaez, G. Sanclimens, A. Moure, A. Arminan, P. Sepulveda, A. Messeguer, M. Vicent and E. Perez-Paya, Journal of medicinal chemistry, 2008, 51, 521-529. 131. S. Bertuglia, F. Veronese and G. Pasut, American Journal of Physiology-Heart and Circulatory Physiology, 2006, 291, H1536-H1544. 132. F. Y. Qiu, M. Zhang, R. Ji, F. S. Du and Z. C. Li, Macromolecular rapid communications, 2015, 36, 2012-2018. 133. A. Duro-Castano, J. Movellan and M. Vicent, Biomaterials science, 2015, 3, 1321-1334.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n134. X. Pang, Y. Jiang, Q. Xiao, A. W. Leung, H. Hua and C. Xu, Journal of Controlled Release, 2016, 222, 116-129. 135. B. Reddy, H. K. Yadav, D. K. Nagesha, A. Raizaday and A. Karim, Journal of nanoscience and nanotechnology, 2015, 15, 4009-4018. 136. D. H. Kim, Y. K. Seo, T. Thambi, G. J. Moon, J. P. Son, G. Li, J. H. Park, J. H. Lee, H. H. Kim and D. S. Lee, Biomaterials, 2015, 61, 115-125. 137. Y. Shi, T. Lammers, G. Storm and W. E. Hennink, Macromolecular bioscience, 2017, 17. 138. T. Yoshitomi and Y. Nagasaki, Nanomedicine, 2011, 6, 509-518. 139. E. Carenza, O. Jordan, P. Martinez-San Segundo, R. Jiřík, Z. Starčuk jr, G. Borchard, A. Rosell and A. Roig, Journal of Materials Chemistry B, 2015, 3, 2538-2544. 140. A. Larrañaga, M. Lomora, J. Sarasua, C. Palivan and A. Pandit, Progress in Materials Science, 2017. 141. J. Gaitzsch, X. Huang and B. Voit, Chem. Rev, 2016, 116, 1053-1093. 142. A. Ghosh, S. Sarkar, A. K. Mandal and N. Das, PLoS One, 2013, 8, e57735. 143. R. T. Chacko, J. Ventura, J. Zhuang and S. Thayumanavan, Advanced drug delivery reviews, 2012, 64, 836-851. 144. Y. Li, D. Maciel, J. o. Rodrigues, X. Shi and H. Tomás, Chemical reviews, 2015, 115, 8564-8608. 145. C. Borselli, H. Storrie, F. Benesch-Lee, D. Shvartsman, C. Cezar, J. W. Lichtman, H. H.\nVandenburgh and D. J. Mooney, Proceedings of the National Academy of Sciences, 2010, 107, 3287-3292.\n146. H. N. Yang, J. H. Choi, J. S. Park, S. Y. Jeon, K. D. Park and K.-H. Park, Biomaterials, 2014, 35, 4716-4728. 147. S. Chen, Q. Bian, P. Wang, X. Zheng, L. Lv, Z. Dang and G. Wang, Polymer Chemistry, 2017. 148. W. Cui, R. Liu, H. Q. Jin, P. Lv, Y. Y. Sun, X. Men, S. N. Yang, X. Z. Qu, Z. Z. Yang and Y. N. Huang, Journal of Controlled Release, 2016, 225, 53-63. 149. A.-M. Caminade, D. Yan and D. K. Smith, Chemical Society Reviews, 2015, 44, 3870-3873. 150. M. K. Mishra, C. A. Beaty, W. G. Lesniak, S. P. Kambhampati, F. Zhang, M. A. Wilson, M. E. Blue, J. C. Troncoso, S. Kannan and M. V. Johnston, ACS nano, 2014, 8, 2134-2147. 151. H. Katsumi, M. Nishikawa, R. Hirosaki, T. Okuda, S. Kawakami, F. Yamashita, M. Hashida, T. Sakane and A. Yamamoto, Molecular pharmaceutics, 2016, 13, 2867-2873. 152. S.-F. Zhang, C. Gao, S. Lü, J. He, M. Liu, C. Wu, Y. Liu, X. Zhang and Z. Liu, Colloids and Surfaces B: Biointerfaces, 2017, 159, 284-292. 153. J. Liu, C. Gu, E. B. Cabigas, K. D. Pendergrass, M. E. Brown, Y. Luo and M. E. Davis, Biomaterials, 2013, 34, 3729-3736. 154. Y. S. Lee, J.-W. Choi, J.-E. Oh, C.-O. Yun and S. W. Kim, Biomaterials, 2016, 97, 164-175. 155. E. Nance, M. Porambo, F. Zhang, M. K. Mishra, M. Buelow, R. Getzenberg, M. Johnston, R. M. Kannan, A. Fatemi and S. Kannan, Journal of Controlled Release, 2015, 214, 112-120. 156. R. Wiwattanapatapee, L. Lomlim and K. Saramunee, Journal of Controlled Release, 2003, 88, 1-9. 157. H. Wang, Q. Huang, H. Chang, J. Xiao and Y. Cheng, Biomaterials science, 2016, 4, 375-390. 158. Y. Fazaeli, O. Akhavan, R. Rahighi, M. R. Aboudzadeh, E. Karimi and H. Afarideh, Materials Science and Engineering: C, 2014, 45, 196-204. 159. B. R. Smith and S. S. Gambhir, Chem. Rev, 2017, 117, 901-986. 160. H. Wang, C. A. Thorling, X. Liang, K. R. Bridle, J. E. Grice, Y. Zhu, D. H. Crawford, Z. P. Xu, X. Liu and M. S. Roberts, Journal of Materials Chemistry B, 2015, 3, 939-958. 161. G. Huang, K.-L. Zhang, S. Chen, S.-H. Li, L.-L. Wang, L.-P. Wang, R. Liu, J. Gao and H.-H. Yang, Journal of Materials Chemistry B, 2017, 5, 3629-3633. 162. A. Fernández and M. Vendrell, Chemical Society Reviews, 2016, 45, 1182-1196. 163. V. Biju, Chemical Society Reviews, 2014, 43, 744-764.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n164. R. F. Minchin and D. J. Martin, Endocrinology, 2010, 151, 474-481. 165. M. M. Meloni, S. Barton, L. Xu, J. C. Kaski, W. Song and T. He, Journal of Materials Chemistry B, 2017, 5, 5714-5725. 166. K. Chen and X. Chen, Current topics in medicinal chemistry, 2010, 10, 1227-1236. 167. F. Kiessling, M. E. Mertens, J. Grimm and T. Lammers, Radiology, 2014, 273, 10-28. 168. R. Hachani, M. Lowdell, M. Birchall, A. Hervault, D. Mertz, S. Begin-Colin and N. T. K. Thanh, Nanoscale, 2016, 8, 3278-3287. 169. K. M. Krishnan, A. B. Pakhomov, Y. Bao, P. Blomqvist, Y. Chun, M. Gonzales, K. Griffin, X. Ji and B. K. Roberts, J Mater Sci, 2006, 41, 793-815. 170. D.-F. Liu, C. Qian, Y.-L. An, D. Chang, S.-H. Ju and G.-J. Teng, Nanoscale, 2014, 6, 15161-15167. 171. K. Nael and W. Kubal, Magnetic Resonance Imaging Clinics, 2016, 24, 293-304. 172. G. H. Gao, J. W. Lee, M. K. Nguyen, G. H. Im, J. Yang, H. Heo, P. Jeon, T. G. Park, J. H. Lee and D. S. Lee, Journal of controlled release, 2011, 155, 11-17. 173. M. J. Gounis, K. van der Marel, M. Marosfoi, M. L. Mazzanti, F. Clarençon, J.-Y. Chueh, A. S. Puri and A. A. Bogdanov, Stroke, 2015, 46, 2991-2997. 174. M. Wiart, N. Davoust, J.-B. Pialat, V. Desestret, S. Moucharrafie, T.-H. Cho, M. Mutin, J.-B. Langlois, O. Beuf and J. Honnorat, Stroke, 2007, 38, 131-137. 175. H. L. Walter, M. Walberer, M. A. Rueger, H. Backes, D. Wiedermann, M. Hoehn, B. Neumaier, R. Graf, G. R. Fink and M. Schroeter, Neuroscience, 2015, 292, 71-80. 176. C.-W. Lu, J.-K. Hsiao, H.-M. Liu and C.-H. Wu, Scientific Reports, 2017, 7. 177. L. P. Nucci, H. R. Silva, V. Giampaoli, J. B. Mamani, M. P. Nucci and L. F. Gamarra, Stem cell research & therapy, 2015, 6, 27. 178. S. Jozwiak, A. Habich, K. Kotulska, A. Sarnowska, T. Kropiwnicki, M. Janowski, E. Jurkiewicz, B.\nLukomska, T. Kmiec, J. Walecki, M. Roszkowski, M. Litwin, T. Oldak, D. Boruczkowski and K. Domanska-Janik, Cell medicine, 2010, 1, 71-80.\n179. H. Hyun, K. Lee, K. H. Min, P. Jeon, K. Kim, S. Y. Jeong, I. C. Kwon, T. G. Park and M. Lee, Journal of controlled release, 2013, 170, 352-357. 180. H. Lee, K. Lee, I. K. Kim and T. G. Park, Biomaterials, 2008, 29, 4709-4718. 181. D. Danila, E. Johnson and P. Kee, Nanomedicine, 2013, 9, 1067-1076. 182. S. Yamazoe, M. Naya, M. Shiota, T. Morikawa, A. Kubo, T. Tani, T. Hishiki, T. Horiuchi, M. Suematsu and M. Kajimura, ACS nano, 2014, 8, 5622-5632. 183. R. Meir, M. Motiei and R. Popovtzer, Nanomedicine, 2014, 9, 2059-2069. 184. L. Ricles, S. Nam, E. Trevino, S. Emelianov and L. Suggs, Journal of Materials Chemistry B, 2014, 2, 8220-8230. 185. H.-J. Yoon, E.-S. Lee, M. Kang, Y. Jeong and J.-H. Park, Journal of Materials Chemistry B, 2015, 3, 2935-2938. 186. Y. Li, J. Zhang, Y. Guo, M. Chen, L. Wang, R. Sun and X. Wang, Journal of Materials Chemistry B, 2016, 4, 6454-6461. 187. K. Shiraishi, Z. Wang, D. Kokuryo, I. Aoki and M. Yokoyama, Journal of Controlled Release, 2017, 253, 165-171. 188. B. Botz, K. Bölcskei, Á. Kemény, Z. Sándor, V. Tékus, G. Sétáló, J. Csepregi, A. Mócsai, E. Pintér and L. Kollár, Journal of biomedical optics, 2015, 20, 016022-016022. 189. H. Y. Yang, M.-S. Jang, G. H. Gao, J. H. Lee and D. S. Lee, Nanoscale, 2016, 8, 12588-12598. 190. H. Y. Yang, Y. Fu, M.-S. Jang, Y. Li, W. P. Yin, T. K. Ahn, J. H. Lee, H. Chae and D. S. Lee, Colloids and Surfaces B: Biointerfaces, 2017, 155, 497-506. 191. C. E. Smith and H. Kong, Langmuir, 2014, 30, 3697-3704. 192. C. E. Smith, A. Shkumatov, S. G. Withers, B. Yang, J. F. Glockner, S. Misra, E. J. Roy, C.-H. Wong, S.\nC. Zimmerman and H. Kong, ACS nano, 2013, 7, 9599-9610.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n193. H. Peng, X. Liu, G. Wang, M. Li, K. M. Bratlie, E. Cochran and Q. Wang, Journal of Materials Chemistry B, 2015, 3, 6856-6870. 194. L. Lu, Y. Wang, M. Cao, M. Chen, B. Lin, X. Duan, F. Zhang, J. Mao, X. Shuai and J. Shen, RSC Advances, 2017, 7, 15041-15052. 195. X. Zhou, M. Ye, Y. Han, J. Tang, Y. Qian, H. Hu and Y. Shen, Biomaterials Science, 2017. 196. H. Kobayashi and M. W. Brechbiel, Current pharmaceutical biotechnology, 2004, 5, 539-549. 197. A. Almutairi, R. Rossin, M. Shokeen, A. Hagooly, A. Ananth, B. Capoccia, S. Guillaudeu, D.\nAbendschein, C. J. Anderson and M. J. Welch, Proceedings of the National Academy of Sciences, 2009, 106, 685-690.\n198. S. A. Papadimitriou, Y. Salinas and M. Resmini, Chemistry-A European Journal, 2016, 22, 3612- 3620. 199. H.-L. Pu, W.-L. Chiang, B. Maiti, Z.-X. Liao, Y.-C. Ho, M. S. Shim, E.-Y. Chuang, Y. Xia and H.-W. Sung, ACS nano, 2014, 8, 1213-1221. 200. C. Kang, W. Cho, M. Park, J. Kim, S. Park, D. Shin, C. Song and D. Lee, Biomaterials, 2016, 85, 195- 203. 201. C. J. Wingard, D. M. Walters, B. L. Cathey, S. C. Hilderbrand, P. Katwa, S. Lin, P. C. Ke, R. Podila, A. Rao and R. M. Lust, Nanotoxicology, 2011, 5, 531-545. 202. Y. Pan, A. Leifert, D. Ruau, S. Neuss, J. Bornemann, G. Schmid, W. Brandau, U. Simon and W. Jahnen-Dechent, Small, 2009, 5, 2067-2076. 203. S. Kim and D. Y. Ryu, J Appl Toxicol, 2013, 33, 78-89. 204. A. K. Patlolla, D. Hackett and P. B. Tchounwou, Molecular and cellular biochemistry, 2015, 399, 257-268. 205. Y. Huang and X. Y. Lu, Sci Adv Mater, 2014, 6, 1907-1918. 206. K. K. Awasthi, A. Awasthi, N. Kumar, P. Roy, K. Awasthi and P. J. John, J Nanopart Res, 2013, 15. 207. N. Mei, Y. B. Zhang, Y. Chen, X. Q. Guo, W. Ding, S. F. Ali, A. S. Biris, P. Rice, M. M. Moore and T. Chen, Environ Mol Mutagen, 2012, 53, 409-419. 208. N. Y. Yin, Q. Liu, J. Y. Liu, B. He, L. Cui, Z. N. Li, Z. J. Yun, G. B. Qu, S. J. Liu, Q. F. Zhou and G. B. Jiang, Small, 2013, 9, 1831-1841. 209. R. de Lima, A. B. Seabra and N. Duran, J Appl Toxicol, 2012, 32, 867-879. 210. A. Dellinger, Z. Zhou, J. Connor, A. Madhankumar, S. Pamujula, C. M. Sayes and C. L. Kepley, Nanomedicine : nanotechnology, biology, and medicine, 2013, 8, 1191-1208. 211. Y.-W. Chen, K. C. Hwang, C.-C. Yen and Y.-L. Lai, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004, 287, R21-R26. 212. J. W. Lee, H. M. Kang, E. J. Won, D. S. Hwang, D. H. Kim, S. J. Lee and J. S. Lee, Aquat Toxicol, 2016, 172, 67-79. 213. J. W. Lee, E. J. Won, H. M. Kang, D. S. Hwang, D. H. Kim, R. K. Kim, S. J. Lee and J. S. Lee, Aquat Toxicol, 2016, 171, 9-19. 214. O. Akhavan, E. Ghaderi, E. Abouei, S. Hatamie and E. Ghasemi, Carbon, 2014, 66, 395-406. 215. O. Akhavan, E. Ghaderi, E. Hashemi and E. Akbari, Carbon, 2015, 95, 309-317. 216. O. Akhavan, M. Abdolahad, A. Esfandiar and M. Mohatashamifar, The Journal of Physical Chemistry C, 2010, 114, 12955-12959. 217. O. Akhavan and E. Ghaderi, Carbon, 2012, 50, 1853-1860. 218. H. Chen, L. Tang, Y. Qin, Y. Yin, J. Tang, W. Tang, X. Sun, Z. Zhang, J. Liu and Q. He, European Journal of Pharmaceutical Sciences, 2010, 40, 94-102. 219. D. A. Mbeh, O. Akhavan, T. Javanbakht, M. Mahmoudi and L. H. Yahia, Applied Surface Science, 2014, 320, 596-601. 220. C. Carnovale, G. Bryant, R. Shukla and V. Bansal, Progress in Materials Science, 2016, 83, 152-\n190.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n221. O. Akhavan, E. Ghaderi and A. Akhavan, Biomaterials, 2012, 33, 8017-8025. 222. G. Wu, P. Li, H. Feng, X. Zhang and P. K. Chu, Journal of Materials Chemistry B, 2015, 3, 2024- 2042. 223. M. Xu, J. Zhu, F. Wang, Y. Xiong, Y. Wu, Q. Wang, J. Weng, Z. Zhang, W. Chen and S. Liu, ACS nano, 2016, 10, 3267-3281. 224. J. O'Brien and K. J. Shea, Accounts Chem Res, 2016, 49, 1200-1210. 225. M. Hadjidemetriou, Z. Al-Ahmady and K. Kostarelos, Nanoscale, 2016, 8, 6948-6957. 226. M. J. Hajipour, J. Raheb, O. Akhavan, S. Arjmand, O. Mashinchian, M. Rahman, M. Abdolahad, V. Serpooshan, S. Laurent and M. Mahmoudi, Nanoscale, 2015, 7, 8978-8994. 227. A. Salvati, A. S. Pitek, M. P. Monopoli, K. Prapainop, F. B. Bombelli, D. R. Hristov, P. M. Kelly, C. Aberg, E. Mahon and K. A. Dawson, Nat Nanotechnol, 2013, 8, 137-143. 228. P. Aggarwal, J. B. Hall, C. B. McLeland, M. A. Dobrovolskaia and S. E. McNeil, Advanced drug delivery reviews, 2009, 61, 428-437. 229. A. Lesniak, F. Fenaroli, M. P. Monopoli, C. Aberg, K. A. Dawson and A. Salvati, ACS nano, 2012, 6, 5845-5857. 230. V. Escamilla-Rivera, M. Uribe-Ramirez, S. Gonzalez-Pozos, O. Lozano, S. Lucas and A. De VizcayaRuiz, Toxicol Lett, 2016, 240, 172-184. 231. H. M. Wong, K. W. K. Yeung, K. O. Lam, V. Tam, P. K. Chu, K. D. K. Luk and K. M. C. Cheung, Biomaterials, 2010, 31, 2084-2096. 232. O. Akhavan, E. Ghaderi and S. A. Shirazian, Colloids and Surfaces B: Biointerfaces, 2015, 126, 313-321. 233. D. P. K. Lankveld, A. G. Oomen, P. Krystek, A. Neigh, A. Troost-de Jong, C. W. Noorlander, J. C. H. Van Eijkeren, R. E. Geertsma and W. H. De Jong, Biomaterials, 2010, 31, 8350-8361. 234. S. Naz, J. Beach, B. Heckert, T. Tummala, O. Pashchenko, T. Banerjee and S. Santra, Nanomedicine, 2017, 12, 545-553. 235. A. V. Kotsuruba, B. S. Kopyak, V. F. Sagach and M. Y. Spivak, International Journal of Physiology and Pathophysiology, 2016, 7. 236. Z. A. Shah and S. B. Vohora, Basic & Clinical Pharmacology & Toxicology, 2002, 90, 254-259. 237. D. Nozdrenko, D. Zavodovskyi, T. Y. Matvienko, S. Y. Zay, K. Bogutska, Y. I. Prylutskyy, U. Ritter and P. Scharff, Nanoscale research letters, 2017, 12, 115. 238. T. Y. Matvienko, D. A. Zavodovskyi, D. A. Vulytska, S. Y. Zay, O. P. Motuziuk, K. I. Bogutska, D. N.\nNozdrenko, Y. P. Sklyarov and Y. I. Prylutskyy, International Journal of Physiology and Pathophysiology, 2017, 8.\n239. P. Hassanzadeh, E. Arbabi, F. Atyabi and R. Dinarvand, Life sciences, 2017, 179, 15-22. 240. P. P. Komane, Y. E. Choonara, L. C. du Toit, P. Kumar, P. P. Kondiah, G. Modi and V. Pillay, Journal of Nanomaterials, 2016, 2016, 34. 241. D. Eshun, R. Saraf, S. Bae, J. Jeganathan, F. Mahmood, S. Dilmen, Q. Ke, D. Lee, P. M. Kang and R. Matyal, Journal of Applied Physiology, 2017, 122, 1388-1397. 242. A. Kowalczuk, R. Trzcinska, B. Trzebicka, A. H. Müller, A. Dworak and C. B. Tsvetanov, Progress in Polymer Science, 2014, 39, 43-86. 243. A. Puri, K. Loomis, B. Smith, J.-H. Lee, A. Yavlovich, E. Heldman and R. Blumenthal, Critical Reviews™ in Therapeutic Drug Carrier Systems, 2009, 26. 244. A. Akbarzadeh, R. Rezaei-Sadabady, S. Davaran, S. W. Joo, N. Zarghami, Y. Hanifehpour, M. Samiei, M. Kouhi and K. Nejati-Koshki, Nanoscale research letters, 2013, 8, 102. 245. C. Li, H. Li, Q. Wang, M. Zhou, M. Li, T. Gong, Z. Zhang and X. Sun, Journal of Controlled Release, 2017, 246, 133-141. 246. K. P. O’Grady, T. E. Kavanaugh, H. Cho, H. Ye, M. K. Gupta, M. C. Madonna, J. Lee, C. M. O’Brien,\nM. C. Skala and K. A. Hasty, ACS Biomaterials Science & Engineering, 2017.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n247. K. M. Poole, C. E. Nelson, R. V. Joshi, J. R. Martin, M. K. Gupta, S. C. Haws, T. E. Kavanaugh, M. C. Skala and C. L. Duvall, Biomaterials, 2015, 41, 166-175. 248. R. H. Staff, M. Gallei, M. Mazurowski, M. Rehahn, R. d. Berger, K. Landfester and D. Crespy, ACS nano, 2012, 6, 9042-9049. 249. W. Cui, R. Liu, H. Jin, P. Lv, Y. Sun, X. Men, S. Yang, X. Qu, Z. Yang and Y. Huang, Journal of Controlled Release, 2016, 225, 53-63. 250. Y. Teng, H. Jin, D. Nan, M. Li, C. Fan, Y. Liu, P. Lv, W. Cui, Y. Sun and H. Hao, Bioactive Materials, 2017. 251. Y. E. Kurtoglu, R. S. Navath, B. Wang, S. Kannan, R. Romero and R. M. Kannan, Biomaterials, 2009, 30, 2112-2121.\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A\n  Page 58 of 58Journal of Materials Chemistry B\nJo ur\nna lo\nfM at\ner ia\nls C\nhe m\nis tr\ny B\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n0 6\nN ov\nem be\nr 20\n17 . D\now nl\noa de\nd by\nU ni\nve rs\nity o\nf R\nea di\nng o\nn 07\n/1 1/\n20 17\n0 0:\n48 :5\n8.\nView Article Online DOI: 10.1039/C7TB01689A"
    } ],
    "references" : [ {
      "title" : "Nature reviews",
      "author" : [ "D.J. Hausenloy", "D.M. Yellon" ],
      "venue" : "Cardiology,",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and O",
      "author" : [ "M. Mahmoudi", "M. Yu", "V. Serpooshan", "J.C. Wu", "R. Langer", "R.T. Lee", "J.M. Kar" ],
      "venue" : "C. Farokhzad, Nature nanotechnology,",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and A",
      "author" : [ "Á. Chamorro", "U. Dirnagl", "X. Urr" ],
      "venue" : "M. Planas, The Lancet Neurology,",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and H",
      "author" : [ "G. Javedan", "F. Shidfar", "S.H. Davoodi", "M. Ajami", "F. Gorjipour", "A. Sureda", "S.M. Nabavi", "M. Dagli" ],
      "venue" : "Pazoki-Toroudi, Molecular nutrition & food research,",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and D",
      "author" : [ "C. Bright", "R. Bright", "E. Churchill", "K.W. Leon" ],
      "venue" : "Mochly-Rosen, Journal,",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and D",
      "author" : [ "C. Pac-Soo", "H. Mathe" ],
      "venue" : "Ma, British journal of anaesthesia,",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and L",
      "author" : [ "C.W. Evans", "K.S. Iye" ],
      "venue" : "C. Hool, Nanomedicine,",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and S",
      "author" : [ "Y. Zhang", "H. Zhang", "Y. Wang", "H. Wu", "B. Zeng", "Y. Zhang", "Q. Tia" ],
      "venue" : "Yang, Journal of Materials Chemistry B,",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and J",
      "author" : [ "M.R. Mohammadi", "A. Nojoomi", "M. Mozafari", "A. Dubnika", "M. Inayathulla" ],
      "venue" : "Rajadas, Journal of Materials Chemistry B,",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and B",
      "author" : [ "M.H. Jazayeri", "H. Amani", "A.A. Pourfatollah", "H. Pazoki-Toroud" ],
      "venue" : "Sedighimoghaddam, Sensing and Bio-Sensing Research,",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and P",
      "author" : [ "B.J. Thompso" ],
      "venue" : "T. Ronaldson, Advances in Pharmacology,",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and G",
      "author" : [ "A. Gaudin", "M. Yemisci", "H. Eroglu", "S. Lepetre-Mouelhi", "O.F. Turkoglu", "B. Dönmez-Demir", "S. Caban", "M.F. Sargon", "S. Garcia-Argot" ],
      "venue" : "Pieters, Nature nanotechnology,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and L",
      "author" : [ "C. Saraiva", "C. Praça", "R. Ferreira", "T. Santos", "L. Ferreir" ],
      "venue" : "Bernardino, Journal of Controlled Release,",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and C",
      "author" : [ "M. Leonor Pinzon-Daza", "I. Campia", "J. Kopecka", "R. Garzón", "D. Ghig" ],
      "venue" : "Rigant, Current drug metabolism,",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and W",
      "author" : [ "T.-T. Zhang", "W. Li", "G. Meng", "P. Wan" ],
      "venue" : "Liao, Biomaterials science,",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and L",
      "author" : [ "C. Tu", "S. Das", "A.B. Baker", "J. Zolda" ],
      "venue" : "J. Suggs, ACS nano,",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and S",
      "author" : [ "S. Panagioto" ],
      "venue" : "Saha, Frontiers in neuroscience,",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and O",
      "author" : [ "E. Birben", "U.M. Sahiner", "C. Sackesen", "S. Erzuru" ],
      "venue" : "Kalayci, World Allergy Organization Journal,",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and S",
      "author" : [ "M. Ajami", "H. Pazoki-Toroudi", "H. Amani", "S.F. Nabavi", "N. Braidy", "R.A. Vacca", "A.G. Atanasov", "A. Moca" ],
      "venue" : "M. Nabavi, Neuroscience & Biobehavioral Reviews,",
      "citeRegEx" : "19",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and S",
      "author" : [ "H. Amani", "M. Ajami", "S.N. Maleki", "H. Pazoki-Toroudi", "M. Daglia", "A.J.T. Sokeng", "A. Di Lorenzo", "S.F. Nabavi", "K.P. Dev" ],
      "venue" : "M. Nabavi, Biochimie,",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and S",
      "author" : [ "H. Pazoki-Toroudi", "H. Amani", "M. Ajami", "S.F. Nabavi", "N. Braidy", "P.D. Kas" ],
      "venue" : "M. Nabavi, Ageing research reviews,",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and W",
      "author" : [ "A. Karakoti", "S. Singh", "J.M. Dowding", "S. Sea" ],
      "venue" : "T. Self, Chemical Society Reviews,",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and S",
      "author" : [ "J.P. Saikia", "S. Paul", "B.K. Konwa" ],
      "venue" : "K. Samdarshi, Colloids and Surfaces B: Biointerfaces,",
      "citeRegEx" : "23",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and A",
      "author" : [ "O. Akhavan", "M. Kalaee", "Z. Alavi", "S. Ghias" ],
      "venue" : "Esfandiar, Carbon,",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and N",
      "author" : [ "R. Sandhir", "A. Yadav", "A. Sunkari" ],
      "venue" : "Singhal, Neurochemistry international,",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and H",
      "author" : [ "K.B. Narayana" ],
      "venue" : "H. Park, Advances in colloid and interface science,",
      "citeRegEx" : "26",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and J",
      "author" : [ "A.Y. Estevez", "B. Stadle" ],
      "venue" : "S. Erlichman, The FASEB Journal,",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and S",
      "author" : [ "N.P. Sardesai", "D. Andreesc" ],
      "venue" : "Andreescu, Journal of the American Chemical Society,",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and H",
      "author" : [ "C.K. Kim", "T. Kim", "I.Y. Choi", "M. Soh", "D. Kim", "Y.J. Kim", "H. Jang", "H.S. Yang", "J.Y. Ki" ],
      "venue" : "K. Park, Angewandte Chemie,",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and C",
      "author" : [ "K.L. Heckman", "W. DeCoteau", "A. Estevez", "K.J. Reed", "W. Costanzo", "D. Sanford", "J.C. Leiter", "J. Clauss", "K. Knap" ],
      "venue" : "Gomez, ACS nano,",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and G",
      "author" : [ "J. Dowding", "W. Song", "K. Bossy", "A. Karakoti", "A. Kumar", "A. Kim", "B. Bossy", "S. Seal", "M. Ellisma" ],
      "venue" : "Perkins, Cell death and differentiation, 2014, 21,",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 1622
    }, {
      "title" : "and J",
      "author" : [ "M. Das", "S. Patil", "N. Bhargava", "J.-F. Kang", "L.M. Riedel", "S. Sea" ],
      "venue" : "J. Hickman, Biomaterials,",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "and W",
      "author" : [ "J.M. Dowding", "S. Sea" ],
      "venue" : "T. Self, Drug delivery and translational research,",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and E",
      "author" : [ "F. Pagliari", "C. Mandoli", "G. Forte", "E. Magnani", "S. Pagliari", "G. Nardone", "S. Licoccia", "M. Minieri", "P. Di Nard" ],
      "venue" : "Traversa, ACS nano,",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and A",
      "author" : [ "Z.S. Bailey", "E. Nilson", "J.A. Bates", "A. Oyalowo", "K.S. Hockey", "V.S.S.S. Sajja", "C. Thorpe", "H. Rogers", "B. Dun" ],
      "venue" : "S. Frey, Journal of neurotrauma,",
      "citeRegEx" : "35",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and A",
      "author" : [ "E.O. Gubernatorova", "X. Liu", "A. Othman", "W.T. Muraoka", "E.P. Koroleva", "S. Andreesc" ],
      "venue" : "V. Tumanov, Advanced Healthcare Materials,",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and W",
      "author" : [ "A. Dhall", "A. Burns", "J. Dowding", "S. Das", "S. Sea" ],
      "venue" : "Self, Environmental Science: Nano,",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and S",
      "author" : [ "K.M. Nas" ],
      "venue" : "Ahmed, Nanomedicine: Nanotechnology, Biology and Medicine,",
      "citeRegEx" : "38",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and P",
      "author" : [ "M. Moglianetti", "E. De Luca", "D. Pedone", "R. Marotta", "T. Catelani", "B. Sartori", "H. Amenitsch", "S.F. Rett" ],
      "venue" : "P. Pompa, Nanoscale,",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and S",
      "author" : [ "T. Hamasaki", "T. Kashiwagi", "T. Imada", "N. Nakamichi", "S. Aramaki", "K. Toh", "S. Morisawa", "H. Shimakoshi", "Y. Hisaed" ],
      "venue" : "Shirahata, Langmuir,",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "and P",
      "author" : [ "D. Pedone", "M. Moglianetti", "E. De Luca", "G. Bard" ],
      "venue" : "P. Pompa, Chemical Society Reviews,",
      "citeRegEx" : "41",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and T",
      "author" : [ "H. Katsumi", "K. Fukui", "K. Sato", "S. Maruyama", "S. Yamashita", "E. Mizumoto", "K. Kusamori", "M. Oyama", "M. San" ],
      "venue" : "Sakane, Metallomics,",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and K",
      "author" : [ "M. Takamiya", "Y. Miyamoto", "T. Yamashita", "K. Deguchi", "Y. Ohta", "Y. Ikeda", "T. Matsuur" ],
      "venue" : "Abe, Journal of neuroscience research,",
      "citeRegEx" : "43",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "and K",
      "author" : [ "M. Takamiya", "Y. Miyamoto", "T. Yamashita", "K. Deguchi", "Y. Oht" ],
      "venue" : "Abe, Neuroscience,",
      "citeRegEx" : "44",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and K",
      "author" : [ "M. Takamiya", "Y. Miyamoto", "T. Yamashita", "K. Deguchi", "Y. Oht" ],
      "venue" : "Abe, Neuroscience,",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "W",
      "author" : [ "C. Chen", "S. Fan", "C. Li", "Y. Chong", "X. Tian", "J. Zheng", "P.P. Fu", "X. Jiang" ],
      "venue" : "G. Wamer and J.-j. Yin, Journal of Materials Chemistry B,",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and H",
      "author" : [ "M. Jazayeri", "H. Amani", "A. Pourfatollah", "A. Avan", "G. Fern" ],
      "venue" : "Pazoki-Toroudi, Cancer gene therapy,",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and Y",
      "author" : [ "Z. Nie", "K.J. Liu", "C.-J. Zhong", "L.-F. Wang", "Y. Yang", "Q. Tia" ],
      "venue" : "Liu, Free Radical Biology and Medicine,",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "S",
      "author" : [ "S. BarathManiKanth", "K. Kalishwaralal", "M. Sriram" ],
      "venue" : "R. K. Pandian, H.-s. Youn, S. Eom and S. Gurunathan, Journal of nanobiotechnology,",
      "citeRegEx" : "49",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "X",
      "author" : [ "Z. Liu", "Y. Shen", "Y. Wu", "Y. Yang", "J. Wu", "P. Zhou" ],
      "venue" : "Lu and Z. Guo, Journal of biomedical nanotechnology,",
      "citeRegEx" : "50",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and M",
      "author" : [ "I. Somasuntharam", "K. Yehl", "S.L. Carroll", "J.T. Maxwell", "M.D. Martinez", "P.-L. Che", "M.E. Brown", "K. Salait" ],
      "venue" : "E. Davis, Biomaterials,",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and J",
      "author" : [ "L. Yang", "J. Sun", "W. Xie", "Y. Li" ],
      "venue" : "Liu, Journal of Materials Chemistry B,",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and S",
      "author" : [ "A. Bhattacharjee", "A. Basu", "T. Sen", "J. Biswa" ],
      "venue" : "Bhattacharya, The Nucleus,",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and C",
      "author" : [ "B. Huang", "J. Zhang", "J. Ho" ],
      "venue" : "Chen, Free Radical Biology and Medicine,",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "and K",
      "author" : [ "R. Soumya", "V. Vineetha", "P.S. Ra" ],
      "venue" : "Raghu, Metallomics,",
      "citeRegEx" : "55",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and A",
      "author" : [ "K. Kalishwaralal", "S. Jeyabharathi", "K. Sunda" ],
      "venue" : "Muthukumaran, Journal of Trace Elements in Medicine and Biology,",
      "citeRegEx" : "56",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and M",
      "author" : [ "W.Z. Teo", "E.L.K. Chng", "Z. Sofe" ],
      "venue" : "Pumera, Nanoscale,",
      "citeRegEx" : "57",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and J",
      "author" : [ "R.M. Lucente-Schultz", "V.C. Moore", "A.D. Leonard", "B.K. Price", "D.V. Kosynkin", "M. Lu", "R. Partha", "J.L. Conyer" ],
      "venue" : "M. Tour, Journal of the American Chemical Society,",
      "citeRegEx" : "58",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "and R",
      "author" : [ "Y. Qiu", "Z. Wang", "A.C. Owens", "I. Kulaots", "Y. Chen", "A.B. Kan" ],
      "venue" : "H. Hurt, Nanoscale,",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "T",
      "author" : [ "N. Martín" ],
      "venue" : "Da Ros and J.-F. Nierengarten, Journal of Materials Chemistry B,",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and L",
      "author" : [ "E. Castro", "A.H. Garcia", "G. Zaval" ],
      "venue" : "Echegoyen, Journal of Materials Chemistry B,",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and G",
      "author" : [ "R. Bakry", "R.M. Vallant", "M. Najam-ul-Haq", "M. Rainer", "Z. Szabo", "C.W. Huc" ],
      "venue" : "K. Bonn, International journal of nanomedicine,",
      "citeRegEx" : "62",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Fullerenes and their potential in nanomedicine",
      "author" : [ "A. Dellinger" ],
      "venue" : "The University of North Carolina at Greensboro,",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2015
    }, {
      "title" : "and K",
      "author" : [ "F. Awan", "E. Bulger", "R.M. Berr" ],
      "venue" : "C. Tam, Cellulose,",
      "citeRegEx" : "64",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and C",
      "author" : [ "J.J. Ryan", "H.R. Bateman", "A. Stover", "G. Gomez", "S.K. Norton", "W. Zhao", "L.B. Schwartz", "R. Len" ],
      "venue" : "L. Kepley, The Journal of immunology,",
      "citeRegEx" : "65",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "and V",
      "author" : [ "B.U. Srđenović", "M.N. Slavić", "K.M. Stankov", "N.V. Kladar", "D.S. Jović", "M.N. Sek" ],
      "venue" : "V. Bogdanović, Hemijska industrija,",
      "citeRegEx" : "66",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and C",
      "author" : [ "S. Foley", "C. Crowley", "M. Smaihi", "C. Bonfils", "B.F. Erlanger", "P. Set" ],
      "venue" : "Larroque, Biochemical and biophysical research communications,",
      "citeRegEx" : "67",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "and C",
      "author" : [ "D. Monti", "L. Moretti", "S. Salvioli", "E. Straface", "W. Malorni", "R. Pellicciari", "G. Schettini", "M. Bisaglia", "C. Pincell" ],
      "venue" : "Fumelli, Biochemical and Biophysical Research Communications,",
      "citeRegEx" : "68",
      "shortCiteRegEx" : null,
      "year" : 2000
    }, {
      "title" : "and R",
      "author" : [ "L.C. Thompson", "R.N. Urankar", "N.A. Holland", "A.K. Vidanapathirana", "J.E. Pitzer", "L. Han", "S.J. Sumner", "A.H. Lewin", "T.R. Fennel" ],
      "venue" : "M. Lust, Toxicological Sciences,",
      "citeRegEx" : "69",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "P",
      "author" : [ "F.-Y. Hsieh", "A. Zhilenkov", "I. Voronov", "E. Khakina", "D. Mischenko" ],
      "venue" : "A. Troshin and S.-h. Hsu, ACS Applied Materials & Interfaces,",
      "citeRegEx" : "70",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and N",
      "author" : [ "A.C. Neto", "F. Guine" ],
      "venue" : "M. Peres, Physics World,",
      "citeRegEx" : "71",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "and M",
      "author" : [ "O. Akhavan", "M. Saadat" ],
      "venue" : "Jannesari, Nano letters,",
      "citeRegEx" : "72",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and S",
      "author" : [ "O.C. Compto" ],
      "venue" : "T. Nguyen, small,",
      "citeRegEx" : "73",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and E",
      "author" : [ "O. Akhava" ],
      "venue" : "Ghaderi, Small,",
      "citeRegEx" : "75",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and R",
      "author" : [ "O. Akhavan", "E. Ghader" ],
      "venue" : "Rahighi, ACS nano,",
      "citeRegEx" : "76",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and M",
      "author" : [ "O. Akhavan", "E. Ghaderi", "R. Rahigh" ],
      "venue" : "Abdolahad, Carbon,",
      "citeRegEx" : "77",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and R",
      "author" : [ "Y. Qiu", "Z. Wang", "A.C.E. Owens", "I. Kulaots", "Y. Chen", "A.B. Kan" ],
      "venue" : "H. Hurt, Nanoscale,",
      "citeRegEx" : "78",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "L",
      "author" : [ "A. Sun" ],
      "venue" : "Mu and X. Hu, ACS Applied Materials & Interfaces,",
      "citeRegEx" : "79",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and J",
      "author" : [ "B.R. Bitner", "D.C. Marcano", "J.M. Berlin", "R.H. Fabian", "L. Cherian", "J.C. Culver", "M.E. Dickinson", "C.S. Robertson", "R.G. Pautler", "T.A. Ken" ],
      "venue" : "M. Tour, ACS nano,",
      "citeRegEx" : "80",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and A",
      "author" : [ "E. Hashemi", "O. Akhavan", "M. Shamsara", "R. Rahighi", "A. Esfandia" ],
      "venue" : "R. Tayefeh, RSC Advances,",
      "citeRegEx" : "81",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and S",
      "author" : [ "D. Suresh", "M.P. Kumar", "H. Nagabhushan" ],
      "venue" : "Sharma, Materials Letters,",
      "citeRegEx" : "82",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "G",
      "author" : [ "V. Ruiz", "L. Yate", "I. García" ],
      "venue" : "Cabanero and H.-J. Grande, Carbon,",
      "citeRegEx" : "83",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and E",
      "author" : [ "O. Akhava" ],
      "venue" : "Ghaderi, Journal of Materials Chemistry B,",
      "citeRegEx" : "84",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and B",
      "author" : [ "J. Park", "B. Kim", "J. Han", "J. Oh", "S. Park", "S. Ryu", "S. Jung", "J.-Y. Shin", "B.S. Le" ],
      "venue" : "H. Hong, ACS nano,",
      "citeRegEx" : "85",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and G",
      "author" : [ "Q. Song", "Z. Jiang", "N. Li", "P. Liu", "L. Liu", "M. Tan" ],
      "venue" : "Cheng, Biomaterials,",
      "citeRegEx" : "86",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and R",
      "author" : [ "O. Akhavan", "E. Ghaderi", "S.A. Shirazia" ],
      "venue" : "Rahighi, Carbon,",
      "citeRegEx" : "87",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "X",
      "author" : [ "Z. Zhou", "Z. Xu", "F. Wang", "Y. Lu", "P. Yin", "C. Jiang", "Y. Liu", "H. Li" ],
      "venue" : "Yu and Y. Sun, OncoTarget,",
      "citeRegEx" : "88",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and A",
      "author" : [ "M.F. De Volder", "S.H. Tawfick", "R.H. Baughma" ],
      "venue" : "J. Hart, science,",
      "citeRegEx" : "89",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and D",
      "author" : [ "P. Watts", "P. Fearon", "W. Hsu", "N. Billingham", "H. Krot" ],
      "venue" : "Walton, Journal of Materials Chemistry,",
      "citeRegEx" : "91",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "and D",
      "author" : [ "L. Dal Bosco", "G.E. Weber", "G.M. Parfitt", "A.P. Cordeiro", "S.K. Sahoo", "C. Fantini", "M.C. Klosterhoff", "L.A. Romano", "C.A. Furtado", "A.P. Santos", "J.M. Monserra" ],
      "venue" : "M. Barros, PloS one,",
      "citeRegEx" : "92",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and V",
      "author" : [ "A.A. Shvedova", "A. Pietroiusti", "B. Fadee" ],
      "venue" : "E. Kagan, Toxicology and applied pharmacology,",
      "citeRegEx" : "94",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "N. Kamaly", "B. Yameen", "J. Wu", "O.C. Farokhzad" ],
      "venue" : "Rev,",
      "citeRegEx" : "95",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and D",
      "author" : [ "C. Kang", "W. Cho", "M. Park", "J. Kim", "S. Park", "D. Shin", "C. Son" ],
      "venue" : "Lee, Biomaterials,",
      "citeRegEx" : "96",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "S",
      "author" : [ "B.-R. Cho", "D.R. Ryu", "K.-S. Lee", "D.-K. Lee", "S. Bae", "D.G. Kang", "Q. Ke" ],
      "venue" : "S. Singh, K.-S. Ha and Y.-G. Kwon, Biomaterials,",
      "citeRegEx" : "97",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and M",
      "author" : [ "X. Liu", "Y. Yan" ],
      "venue" : "W. Urban, Macromolecular Rapid Communications,",
      "citeRegEx" : "98",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and X",
      "author" : [ "Q. Xu", "C. He", "C. Xia" ],
      "venue" : "Chen, Macromolecular bioscience,",
      "citeRegEx" : "99",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and X",
      "author" : [ "R. Fang", "H. Xu", "W. Cao", "L. Yan" ],
      "venue" : "Zhang, Polymer Chemistry,",
      "citeRegEx" : "100",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and A",
      "author" : [ "C. Tapeino" ],
      "venue" : "Pandit, Advanced Materials,",
      "citeRegEx" : "101",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and P",
      "author" : [ "D. Lee", "S. Bae", "Q. Ke", "J. Lee", "B. Song", "S.A. Karumanchi", "G. Khang", "H.S. Cho" ],
      "venue" : "M. Kang, Journal of controlled release,",
      "citeRegEx" : "102",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and P",
      "author" : [ "D. Lee", "S. Bae", "D. Hong", "H. Lim", "J.H. Yoon", "O. Hwang", "S. Park", "Q. Ke", "G. Khan" ],
      "venue" : "M. Kang, Sci Rep-Uk,",
      "citeRegEx" : "103",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and D",
      "author" : [ "J. Kwon", "J. Kim", "S. Park", "G. Khang", "P.M. Kan" ],
      "venue" : "Lee, Biomacromolecules,",
      "citeRegEx" : "104",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and R",
      "author" : [ "C. Tang", "D. Amin", "P.B. Messersmith", "J.E. Anthon" ],
      "venue" : "K. Prud’homme, Langmuir,",
      "citeRegEx" : "105",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "T",
      "author" : [ "W. Cao", "Y. Gu" ],
      "venue" : "Li and H. Xu, Chemical Communications,",
      "citeRegEx" : "106",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "K",
      "author" : [ "K. Ulbrich" ],
      "venue" : "i. Holá, V. Šubr, A. Bakandritsos, J. Tucek and R. Zboril, Chemical reviews,",
      "citeRegEx" : "107",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and V",
      "author" : [ "D. Eckmann", "R. Composto", "A. Tsourka" ],
      "venue" : "Muzykantov, Journal of Materials Chemistry B,",
      "citeRegEx" : "108",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and Z",
      "author" : [ "Q. Han", "X. Jia", "Y. Qian", "Z. Wang", "S. Yang", "Y. Jia", "W. Wan" ],
      "venue" : "Hu, Journal of Materials Chemistry B,",
      "citeRegEx" : "109",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "W",
      "author" : [ "Y.-Z. Zhao", "M. Lin", "Q. Lin" ],
      "venue" : "Yang, X.-C. Yu, F.-R. Tian, K.-L. Mao, J.-J. Yang, C.-T. Lu and H. L. Wong, Journal of Controlled Release,",
      "citeRegEx" : "110",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and H",
      "author" : [ "S. Liu", "S.R. Levin" ],
      "venue" : "R. Winn, Journal of experimental stroke & translational medicine,",
      "citeRegEx" : "111",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "and H",
      "author" : [ "S. Liu", "S.R. Levin" ],
      "venue" : "R. Winn, Journal of experimental stroke & translational medicine,",
      "citeRegEx" : "112",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "X",
      "author" : [ "C. Chen", "Z. Duan", "Y. Yuan", "R. Li", "L. Pang", "J. Liang" ],
      "venue" : "Xu and J. Wang, ACS Applied Materials & Interfaces,",
      "citeRegEx" : "114",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Q",
      "author" : [ "Z. Wang", "Y. Zhao", "Y. Jiang", "W. Lv", "L. Wu", "B. Wang", "L. Lv" ],
      "venue" : "Xu and H. Xin, Scientific reports,",
      "citeRegEx" : "115",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and Y",
      "author" : [ "S. Yajima", "S. Miyagawa", "S. Fukushima", "Y. Sakai", "A. Harada", "H. Iseoka", "M. Shiozaki", "Y. Mori", "Y. Yoshiok" ],
      "venue" : "Sawa, Journal,",
      "citeRegEx" : "117",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and A",
      "author" : [ "M.J. Lipinski", "M.T. Albelda", "J.C. Frias", "S.A. Anderson", "D. Luger", "P.C. Westman", "R.O. Escarcega", "D.G. Hellinga", "R. Waksma" ],
      "venue" : "E. Arai, Cardiovascular Revascularization Medicine,",
      "citeRegEx" : "118",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and B",
      "author" : [ "V.J. Carid" ],
      "venue" : "L. Zaret, Science,",
      "citeRegEx" : "119",
      "shortCiteRegEx" : null,
      "year" : 1977
    }, {
      "title" : "and V",
      "author" : [ "W.C. Hartner", "D.D. Verma", "T.S. Levchenko", "E.A. Bernstei" ],
      "venue" : "P. Torchilin, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology,",
      "citeRegEx" : "120",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "and D",
      "author" : [ "T. Dvir", "M. Bauer", "A. Schroeder", "J.H. Tsui", "D.G. Anderson", "R. Langer", "R. Lia" ],
      "venue" : "S. Kohane, Nano letters,",
      "citeRegEx" : "121",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "and H",
      "author" : [ "N.M. Morsi", "D.M. Ghora" ],
      "venue" : "A. Badie, Pharmaceutical development and technology,",
      "citeRegEx" : "122",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and H",
      "author" : [ "Z. Liu", "L. Zhang", "Q. He", "X. Liu", "O.C. Ikechukwu", "L. Tong", "L. Guo", "H. Yang", "Q. Zhan" ],
      "venue" : "Zhao, International journal of pharmaceutics,",
      "citeRegEx" : "124",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Nature reviews",
      "author" : [ "C.J. Cheng", "G.T. Tietjen", "J.K. Saucier-Sawyer", "W.M. Saltzman" ],
      "venue" : "Drug discovery,",
      "citeRegEx" : "127",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and M",
      "author" : [ "S. Ganta", "H. Devalapally", "A. Shahiwal" ],
      "venue" : "Amiji, Journal of controlled release : official journal of the Controlled Release Society,",
      "citeRegEx" : "128",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "and W",
      "author" : [ "G. Saravanakumar", "J. Ki" ],
      "venue" : "J. Kim, Advanced Science,",
      "citeRegEx" : "129",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and E",
      "author" : [ "L. Mondragon", "M. Orzaez", "G. Sanclimens", "A. Moure", "A. Arminan", "P. Sepulveda", "A. Messeguer", "M. Vicen" ],
      "venue" : "Perez-Paya, Journal of medicinal chemistry,",
      "citeRegEx" : "130",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "and G",
      "author" : [ "S. Bertuglia", "F. Verones" ],
      "venue" : "Pasut, American Journal of Physiology-Heart and Circulatory Physiology,",
      "citeRegEx" : "131",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "F",
      "author" : [ "F.Y. Qiu", "M. Zhang", "R. Ji" ],
      "venue" : "S. Du and Z. C. Li, Macromolecular rapid communications,",
      "citeRegEx" : "132",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and M",
      "author" : [ "A. Duro-Castano", "J. Movella" ],
      "venue" : "Vicent, Biomaterials science,",
      "citeRegEx" : "133",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and C",
      "author" : [ "X. Pang", "Y. Jiang", "Q. Xiao", "A.W. Leung", "H. Hu" ],
      "venue" : "Xu, Journal of Controlled Release,",
      "citeRegEx" : "134",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and A",
      "author" : [ "B. Reddy", "H.K. Yadav", "D.K. Nagesha", "A. Raizada" ],
      "venue" : "Karim, Journal of nanoscience and nanotechnology,",
      "citeRegEx" : "135",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and D",
      "author" : [ "D.H. Kim", "Y.K. Seo", "T. Thambi", "G.J. Moon", "J.P. Son", "G. Li", "J.H. Park", "J.H. Lee", "H.H. Ki" ],
      "venue" : "S. Lee, Biomaterials,",
      "citeRegEx" : "136",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and W",
      "author" : [ "Y. Shi", "T. Lammers", "G. Stor" ],
      "venue" : "E. Hennink, Macromolecular bioscience,",
      "citeRegEx" : "137",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and Y",
      "author" : [ "T. Yoshitom" ],
      "venue" : "Nagasaki, Nanomedicine,",
      "citeRegEx" : "138",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "jr, G",
      "author" : [ "E. Carenza", "O. Jordan", "P. Martinez-San Segundo", "R. Jiřík", "Z. Starču" ],
      "venue" : "Borchard, A. Rosell and A. Roig, Journal of Materials Chemistry B,",
      "citeRegEx" : "139",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and A",
      "author" : [ "A. Larrañaga", "M. Lomora", "J. Sarasua", "C. Paliva" ],
      "venue" : "Pandit, Progress in Materials Science,",
      "citeRegEx" : "140",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Chem",
      "author" : [ "J. Gaitzsch", "X. Huang", "B. Voit" ],
      "venue" : "Rev,",
      "citeRegEx" : "141",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and N",
      "author" : [ "A. Ghosh", "S. Sarkar", "A.K. Manda" ],
      "venue" : "Das, PLoS One,",
      "citeRegEx" : "142",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and S",
      "author" : [ "R.T. Chacko", "J. Ventura", "J. Zhuan" ],
      "venue" : "Thayumanavan, Advanced drug delivery reviews,",
      "citeRegEx" : "143",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "J",
      "author" : [ "Y. Li", "D. Maciel" ],
      "venue" : "o. Rodrigues, X. Shi and H. Tomás, Chemical reviews,",
      "citeRegEx" : "144",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and D",
      "author" : [ "C. Borselli", "H. Storrie", "F. Benesch-Lee", "D. Shvartsman", "C. Cezar", "J.W. Lichtman", "H.H. Vandenburg" ],
      "venue" : "J. Mooney, Proceedings of the National Academy of Sciences,",
      "citeRegEx" : "145",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "K",
      "author" : [ "H.N. Yang", "J.H. Choi", "J.S. Park", "S.Y. Jeon" ],
      "venue" : "D. Park and K.-H. Park, Biomaterials,",
      "citeRegEx" : "146",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and G",
      "author" : [ "S. Chen", "Q. Bian", "P. Wang", "X. Zheng", "L. Lv", "Z. Dan" ],
      "venue" : "Wang, Polymer Chemistry,",
      "citeRegEx" : "147",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and Y",
      "author" : [ "W. Cui", "R. Liu", "H.Q. Jin", "P. Lv", "Y.Y. Sun", "X. Men", "S.N. Yang", "X.Z. Qu", "Z.Z. Yan" ],
      "venue" : "N. Huang, Journal of Controlled Release,",
      "citeRegEx" : "148",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and D",
      "author" : [ "A.-M. Caminade", "D. Ya" ],
      "venue" : "K. Smith, Chemical Society Reviews,",
      "citeRegEx" : "149",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and M",
      "author" : [ "M.K. Mishra", "C.A. Beaty", "W.G. Lesniak", "S.P. Kambhampati", "F. Zhang", "M.A. Wilson", "M.E. Blue", "J.C. Troncoso", "S. Kanna" ],
      "venue" : "V. Johnston, ACS nano,",
      "citeRegEx" : "150",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and A",
      "author" : [ "H. Katsumi", "M. Nishikawa", "R. Hirosaki", "T. Okuda", "S. Kawakami", "F. Yamashita", "M. Hashida", "T. Sakan" ],
      "venue" : "Yamamoto, Molecular pharmaceutics,",
      "citeRegEx" : "151",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and Z",
      "author" : [ "S.-F. Zhang", "C. Gao", "S. Lü", "J. He", "M. Liu", "C. Wu", "Y. Liu", "X. Zhan" ],
      "venue" : "Liu, Colloids and Surfaces B: Biointerfaces,",
      "citeRegEx" : "152",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and M",
      "author" : [ "J. Liu", "C. Gu", "E.B. Cabigas", "K.D. Pendergrass", "M.E. Brown", "Y. Lu" ],
      "venue" : "E. Davis, Biomaterials,",
      "citeRegEx" : "153",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and S",
      "author" : [ "Y.S. Lee", "J.-W. Choi", "J.-E. Oh", "C.-O. Yu" ],
      "venue" : "W. Kim, Biomaterials,",
      "citeRegEx" : "154",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and S",
      "author" : [ "E. Nance", "M. Porambo", "F. Zhang", "M.K. Mishra", "M. Buelow", "R. Getzenberg", "M. Johnston", "R.M. Kannan", "A. Fatem" ],
      "venue" : "Kannan, Journal of Controlled Release,",
      "citeRegEx" : "155",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and K",
      "author" : [ "R. Wiwattanapatapee", "L. Lomli" ],
      "venue" : "Saramunee, Journal of Controlled Release,",
      "citeRegEx" : "156",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "and Y",
      "author" : [ "H. Wang", "Q. Huang", "H. Chang", "J. Xia" ],
      "venue" : "Cheng, Biomaterials science,",
      "citeRegEx" : "157",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and H",
      "author" : [ "Y. Fazaeli", "O. Akhavan", "R. Rahighi", "M.R. Aboudzadeh", "E. Karim" ],
      "venue" : "Afarideh, Materials Science and Engineering: C,",
      "citeRegEx" : "158",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "B.R. Smith", "S.S. Gambhir" ],
      "venue" : "Rev,",
      "citeRegEx" : "159",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and M",
      "author" : [ "H. Wang", "C.A. Thorling", "X. Liang", "K.R. Bridle", "J.E. Grice", "Y. Zhu", "D.H. Crawford", "Z.P. Xu", "X. Li" ],
      "venue" : "S. Roberts, Journal of Materials Chemistry B,",
      "citeRegEx" : "160",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "J",
      "author" : [ "G. Huang", "K.-L. Zhang", "S. Chen", "S.-H. Li", "L.-L. Wang", "L.-P. Wang", "R. Liu" ],
      "venue" : "Gao and H.-H. Yang, Journal of Materials Chemistry B,",
      "citeRegEx" : "161",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and M",
      "author" : [ "A. Fernánde" ],
      "venue" : "Vendrell, Chemical Society Reviews,",
      "citeRegEx" : "162",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "fM  at  er  ia  ls  C  he  m  is  tr  y  B  A  cc  ep  te  d  M  an  us  cr  ip  t Pu  bl  is  he  d  on  0  6  N  ov  em  be  r  20  17  .  D  ow  nl  oa  de  d  by  U  ni  ve  rs  ity  o  f  R",
      "author" : [ "V. Biju" ],
      "venue" : "Chemical Society Reviews,",
      "citeRegEx" : "163",
      "shortCiteRegEx" : "163",
      "year" : 2014
    }, {
      "title" : "and D",
      "author" : [ "R.F. Minchi" ],
      "venue" : "J. Martin, Endocrinology,",
      "citeRegEx" : "164",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and T",
      "author" : [ "M.M. Meloni", "S. Barton", "L. Xu", "J.C. Kaski", "W. Son" ],
      "venue" : "He, Journal of Materials Chemistry B,",
      "citeRegEx" : "165",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and X",
      "author" : [ "K. Che" ],
      "venue" : "Chen, Current topics in medicinal chemistry,",
      "citeRegEx" : "166",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and T",
      "author" : [ "F. Kiessling", "M.E. Mertens", "J. Grim" ],
      "venue" : "Lammers, Radiology,",
      "citeRegEx" : "167",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and N",
      "author" : [ "R. Hachani", "M. Lowdell", "M. Birchall", "A. Hervault", "D. Mertz", "S. Begin-Coli" ],
      "venue" : "T. K. Thanh, Nanoscale,",
      "citeRegEx" : "168",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "X",
      "author" : [ "K.M. Krishnan", "A.B. Pakhomov", "Y. Bao", "P. Blomqvist", "Y. Chun", "M. Gonzales", "K. Griffin" ],
      "venue" : "Ji and B. K. Roberts, J Mater Sci,",
      "citeRegEx" : "169",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "D",
      "author" : [ "D.-F. Liu", "C. Qian", "Y.-L. An" ],
      "venue" : "Chang, S.-H. Ju and G.-J. Teng, Nanoscale,",
      "citeRegEx" : "170",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and W",
      "author" : [ "K. Nae" ],
      "venue" : "Kubal, Magnetic Resonance Imaging Clinics,",
      "citeRegEx" : "171",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and D",
      "author" : [ "G.H. Gao", "J.W. Lee", "M.K. Nguyen", "G.H. Im", "J. Yang", "H. Heo", "P. Jeon", "T.G. Park", "J.H. Le" ],
      "venue" : "S. Lee, Journal of controlled release,",
      "citeRegEx" : "172",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "K",
      "author" : [ "M.J. Gounis" ],
      "venue" : "van der Marel, M. Marosfoi, M. L. Mazzanti, F. Clarençon, J.-Y. Chueh, A. S. Puri and A. A. Bogdanov, Stroke,",
      "citeRegEx" : "173",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and J",
      "author" : [ "M. Wiart", "N. Davoust", "J.-B. Pialat", "V. Desestret", "S. Moucharrafie", "T.-H. Cho", "M. Mutin", "J.-B. Langlois", "O. Beu" ],
      "venue" : "Honnorat, Stroke,",
      "citeRegEx" : "174",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "and M",
      "author" : [ "H.L. Walter", "M. Walberer", "M.A. Rueger", "H. Backes", "D. Wiedermann", "M. Hoehn", "B. Neumaier", "R. Graf", "G.R. Fin" ],
      "venue" : "Schroeter, Neuroscience,",
      "citeRegEx" : "175",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and L",
      "author" : [ "L.P. Nucci", "H.R. Silva", "V. Giampaoli", "J.B. Mamani", "M.P. Nucc" ],
      "venue" : "F. Gamarra, Stem cell research & therapy,",
      "citeRegEx" : "177",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and K",
      "author" : [ "S. Jozwiak", "A. Habich", "K. Kotulska", "A. Sarnowska", "T. Kropiwnicki", "M. Janowski", "E. Jurkiewicz", "B. Lukomska", "T. Kmiec", "J. Walecki", "M. Roszkowski", "M. Litwin", "T. Oldak", "D. Boruczkowsk" ],
      "venue" : "Domanska-Janik, Cell medicine,",
      "citeRegEx" : "178",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and M",
      "author" : [ "H. Hyun", "K. Lee", "K.H. Min", "P. Jeon", "K. Kim", "S.Y. Jeong", "I.C. Kwon", "T.G. Par" ],
      "venue" : "Lee, Journal of controlled release,",
      "citeRegEx" : "179",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and T",
      "author" : [ "H. Lee", "K. Lee", "I.K. Ki" ],
      "venue" : "G. Park, Biomaterials,",
      "citeRegEx" : "180",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "and P",
      "author" : [ "D. Danila", "E. Johnso" ],
      "venue" : "Kee, Nanomedicine,",
      "citeRegEx" : "181",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and M",
      "author" : [ "S. Yamazoe", "M. Naya", "M. Shiota", "T. Morikawa", "A. Kubo", "T. Tani", "T. Hishiki", "T. Horiuchi", "M. Suemats" ],
      "venue" : "Kajimura, ACS nano,",
      "citeRegEx" : "182",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and R",
      "author" : [ "R. Meir", "M. Motie" ],
      "venue" : "Popovtzer, Nanomedicine,",
      "citeRegEx" : "183",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and L",
      "author" : [ "L. Ricles", "S. Nam", "E. Trevino", "S. Emeliano" ],
      "venue" : "Suggs, Journal of Materials Chemistry B,",
      "citeRegEx" : "184",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Y",
      "author" : [ "H.-J. Yoon", "E.-S. Lee", "M. Kang" ],
      "venue" : "Jeong and J.-H. Park, Journal of Materials Chemistry B,",
      "citeRegEx" : "185",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and X",
      "author" : [ "Y. Li", "J. Zhang", "Y. Guo", "M. Chen", "L. Wang", "R. Su" ],
      "venue" : "Wang, Journal of Materials Chemistry B,",
      "citeRegEx" : "186",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and M",
      "author" : [ "K. Shiraishi", "Z. Wang", "D. Kokuryo", "I. Aok" ],
      "venue" : "Yokoyama, Journal of Controlled Release,",
      "citeRegEx" : "187",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and L",
      "author" : [ "B. Botz", "K. Bölcskei", "Á. Kemény", "Z. Sándor", "V. Tékus", "G. Sétáló", "J. Csepregi", "A. Mócsai", "E. Pinté" ],
      "venue" : "Kollár, Journal of biomedical optics,",
      "citeRegEx" : "188",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and D",
      "author" : [ "H.Y. Yang", "M.-S. Jang", "G.H. Gao", "J.H. Le" ],
      "venue" : "S. Lee, Nanoscale,",
      "citeRegEx" : "189",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and D",
      "author" : [ "H.Y. Yang", "Y. Fu", "M.-S. Jang", "Y. Li", "W.P. Yin", "T.K. Ahn", "J.H. Lee", "H. Cha" ],
      "venue" : "S. Lee, Colloids and Surfaces B: Biointerfaces,",
      "citeRegEx" : "190",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and H",
      "author" : [ "C.E. Smit" ],
      "venue" : "Kong, Langmuir,",
      "citeRegEx" : "191",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and H",
      "author" : [ "C.E. Smith", "A. Shkumatov", "S.G. Withers", "B. Yang", "J.F. Glockner", "S. Misra", "E.J. Roy", "C.-H. Wong", "S.C. Zimmerma" ],
      "venue" : "Kong, ACS nano,",
      "citeRegEx" : "192",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and Q",
      "author" : [ "H. Peng", "X. Liu", "G. Wang", "M. Li", "K.M. Bratlie", "E. Cochra" ],
      "venue" : "Wang, Journal of Materials Chemistry B,",
      "citeRegEx" : "193",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and J",
      "author" : [ "L. Lu", "Y. Wang", "M. Cao", "M. Chen", "B. Lin", "X. Duan", "F. Zhang", "J. Mao", "X. Shua" ],
      "venue" : "Shen, RSC Advances,",
      "citeRegEx" : "194",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "H",
      "author" : [ "X. Zhou", "M. Ye", "Y. Han", "J. Tang", "Y. Qian" ],
      "venue" : "Hu and Y. Shen, Biomaterials Science,",
      "citeRegEx" : "195",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and M",
      "author" : [ "H. Kobayash" ],
      "venue" : "W. Brechbiel, Current pharmaceutical biotechnology,",
      "citeRegEx" : "196",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "and M",
      "author" : [ "A. Almutairi", "R. Rossin", "M. Shokeen", "A. Hagooly", "A. Ananth", "B. Capoccia", "S. Guillaudeu", "D. Abendschein", "C.J. Anderso" ],
      "venue" : "J. Welch, Proceedings of the National Academy of Sciences,",
      "citeRegEx" : "197",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "and M",
      "author" : [ "S.A. Papadimitriou", "Y. Salina" ],
      "venue" : "Resmini, Chemistry-A European Journal,",
      "citeRegEx" : "198",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Y",
      "author" : [ "H.-L. Pu", "W.-L. Chiang", "B. Maiti", "Z.-X. Liao", "Y.-C. Ho", "M.S. Shim", "E.-Y. Chuang" ],
      "venue" : "Xia and H.-W. Sung, ACS nano,",
      "citeRegEx" : "199",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and D",
      "author" : [ "C. Kang", "W. Cho", "M. Park", "J. Kim", "S. Park", "D. Shin", "C. Son" ],
      "venue" : "Lee, Biomaterials,",
      "citeRegEx" : "200",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and R",
      "author" : [ "C.J. Wingard", "D.M. Walters", "B.L. Cathey", "S.C. Hilderbrand", "P. Katwa", "S. Lin", "P.C. Ke", "R. Podila", "A. Ra" ],
      "venue" : "M. Lust, Nanotoxicology,",
      "citeRegEx" : "201",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "and W",
      "author" : [ "Y. Pan", "A. Leifert", "D. Ruau", "S. Neuss", "J. Bornemann", "G. Schmid", "W. Brandau", "U. Simo" ],
      "venue" : "Jahnen-Dechent, Small,",
      "citeRegEx" : "202",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "and D",
      "author" : [ "S. Ki" ],
      "venue" : "Y. Ryu, J Appl Toxicol,",
      "citeRegEx" : "203",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and P",
      "author" : [ "A.K. Patlolla", "D. Hacket" ],
      "venue" : "B. Tchounwou, Molecular and cellular biochemistry,",
      "citeRegEx" : "204",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and X",
      "author" : [ "Y. Huan" ],
      "venue" : "Y. Lu, Sci Adv Mater,",
      "citeRegEx" : "205",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and P",
      "author" : [ "K.K. Awasthi", "A. Awasthi", "N. Kumar", "P. Roy", "K. Awasth" ],
      "venue" : "J. John, J Nanopart Res,",
      "citeRegEx" : "206",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and T",
      "author" : [ "N. Mei", "Y.B. Zhang", "Y. Chen", "X.Q. Guo", "W. Ding", "S.F. Ali", "A.S. Biris", "P. Rice", "M.M. Moor" ],
      "venue" : "Chen, Environ Mol Mutagen,",
      "citeRegEx" : "207",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and G",
      "author" : [ "N.Y. Yin", "Q. Liu", "J.Y. Liu", "B. He", "L. Cui", "Z.N. Li", "Z.J. Yun", "G.B. Qu", "S.J. Liu", "Q.F. Zho" ],
      "venue" : "B. Jiang, Small,",
      "citeRegEx" : "208",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and C",
      "author" : [ "A. Dellinger", "Z. Zhou", "J. Connor", "A. Madhankumar", "S. Pamujula", "C.M. Saye" ],
      "venue" : "L. Kepley, Nanomedicine : nanotechnology, biology, and medicine,",
      "citeRegEx" : "210",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "K",
      "author" : [ "Y.-W. Chen" ],
      "venue" : "C. Hwang, C.-C. Yen and Y.-L. Lai, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology,",
      "citeRegEx" : "211",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "and J",
      "author" : [ "J.W. Lee", "H.M. Kang", "E.J. Won", "D.S. Hwang", "D.H. Kim", "S.J. Le" ],
      "venue" : "S. Lee, Aquat Toxicol,",
      "citeRegEx" : "212",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and J",
      "author" : [ "J.W. Lee", "E.J. Won", "H.M. Kang", "D.S. Hwang", "D.H. Kim", "R.K. Kim", "S.J. Le" ],
      "venue" : "S. Lee, Aquat Toxicol,",
      "citeRegEx" : "213",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and E",
      "author" : [ "O. Akhavan", "E. Ghaderi", "E. Abouei", "S. Hatami" ],
      "venue" : "Ghasemi, Carbon,",
      "citeRegEx" : "214",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and E",
      "author" : [ "O. Akhavan", "E. Ghaderi", "E. Hashem" ],
      "venue" : "Akbari, Carbon,",
      "citeRegEx" : "215",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and M",
      "author" : [ "O. Akhavan", "M. Abdolahad", "A. Esfandia" ],
      "venue" : "Mohatashamifar, The Journal of Physical Chemistry C,",
      "citeRegEx" : "216",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and E",
      "author" : [ "O. Akhava" ],
      "venue" : "Ghaderi, Carbon,",
      "citeRegEx" : "217",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and Q",
      "author" : [ "H. Chen", "L. Tang", "Y. Qin", "Y. Yin", "J. Tang", "W. Tang", "X. Sun", "Z. Zhang", "J. Li" ],
      "venue" : "He, European Journal of Pharmaceutical Sciences,",
      "citeRegEx" : "218",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and L",
      "author" : [ "D.A. Mbeh", "O. Akhavan", "T. Javanbakht", "M. Mahmoud" ],
      "venue" : "H. Yahia, Applied Surface Science,",
      "citeRegEx" : "219",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and V",
      "author" : [ "C. Carnovale", "G. Bryant", "R. Shukl" ],
      "venue" : "Bansal, Progress in Materials Science,",
      "citeRegEx" : "220",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and A",
      "author" : [ "O. Akhavan", "E. Ghader" ],
      "venue" : "Akhavan, Biomaterials,",
      "citeRegEx" : "221",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and P",
      "author" : [ "G. Wu", "P. Li", "H. Feng", "X. Zhan" ],
      "venue" : "K. Chu, Journal of Materials Chemistry B,",
      "citeRegEx" : "222",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and S",
      "author" : [ "M. Xu", "J. Zhu", "F. Wang", "Y. Xiong", "Y. Wu", "Q. Wang", "J. Weng", "Z. Zhang", "W. Che" ],
      "venue" : "Liu, ACS nano,",
      "citeRegEx" : "223",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and K",
      "author" : [ "J. O'Brie" ],
      "venue" : "J. Shea, Accounts Chem Res,",
      "citeRegEx" : "224",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and K",
      "author" : [ "M. Hadjidemetriou", "Z. Al-Ahmad" ],
      "venue" : "Kostarelos, Nanoscale,",
      "citeRegEx" : "225",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and M",
      "author" : [ "M.J. Hajipour", "J. Raheb", "O. Akhavan", "S. Arjmand", "O. Mashinchian", "M. Rahman", "M. Abdolahad", "V. Serpooshan", "S. Lauren" ],
      "venue" : "Mahmoudi, Nanoscale,",
      "citeRegEx" : "226",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and K",
      "author" : [ "A. Salvati", "A.S. Pitek", "M.P. Monopoli", "K. Prapainop", "F.B. Bombelli", "D.R. Hristov", "P.M. Kelly", "C. Aberg", "E. Maho" ],
      "venue" : "A. Dawson, Nat Nanotechnol,",
      "citeRegEx" : "227",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and S",
      "author" : [ "P. Aggarwal", "J.B. Hall", "C.B. McLeland", "M.A. Dobrovolskai" ],
      "venue" : "E. McNeil, Advanced drug delivery reviews,",
      "citeRegEx" : "228",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "and A",
      "author" : [ "A. Lesniak", "F. Fenaroli", "M.P. Monopoli", "C. Aberg", "K.A. Dawso" ],
      "venue" : "Salvati, ACS nano,",
      "citeRegEx" : "229",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and A",
      "author" : [ "V. Escamilla-Rivera", "M. Uribe-Ramirez", "S. Gonzalez-Pozos", "O. Lozano", "S. Luca" ],
      "venue" : "De VizcayaRuiz, Toxicol Lett,",
      "citeRegEx" : "230",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and K",
      "author" : [ "H.M. Wong", "K.W.K. Yeung", "K.O. Lam", "V. Tam", "P.K. Chu", "K.D.K. Lu" ],
      "venue" : "M. C. Cheung, Biomaterials,",
      "citeRegEx" : "231",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and S",
      "author" : [ "O. Akhavan", "E. Ghader" ],
      "venue" : "A. Shirazian, Colloids and Surfaces B: Biointerfaces,",
      "citeRegEx" : "232",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "and W",
      "author" : [ "D.P.K. Lankveld", "A.G. Oomen", "P. Krystek", "A. Neigh", "A. Troost-de Jong", "C.W. Noorlander", "J.C.H. Van Eijkeren", "R.E. Geertsm" ],
      "venue" : "H. De Jong, Biomaterials,",
      "citeRegEx" : "233",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "and S",
      "author" : [ "S. Naz", "J. Beach", "B. Heckert", "T. Tummala", "O. Pashchenko", "T. Banerje" ],
      "venue" : "Santra, Nanomedicine,",
      "citeRegEx" : "234",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and M",
      "author" : [ "A.V. Kotsuruba", "B.S. Kopyak", "V.F. Sagac" ],
      "venue" : "Y. Spivak, International Journal of Physiology and Pathophysiology,",
      "citeRegEx" : "235",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and S",
      "author" : [ "Z.A. Sha" ],
      "venue" : "B. Vohora, Basic & Clinical Pharmacology & Toxicology,",
      "citeRegEx" : "236",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "and P",
      "author" : [ "D. Nozdrenko", "D. Zavodovskyi", "T.Y. Matvienko", "S.Y. Zay", "K. Bogutska", "Y.I. Prylutskyy", "U. Ritte" ],
      "venue" : "Scharff, Nanoscale research letters,",
      "citeRegEx" : "237",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and Y",
      "author" : [ "T.Y. Matvienko", "D.A. Zavodovskyi", "D.A. Vulytska", "S.Y. Zay", "O.P. Motuziuk", "K.I. Bogutska", "D.N. Nozdrenko", "Y.P. Sklyaro" ],
      "venue" : "I. Prylutskyy, International Journal of Physiology and Pathophysiology,",
      "citeRegEx" : "238",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and R",
      "author" : [ "P. Hassanzadeh", "E. Arbabi", "F. Atyab" ],
      "venue" : "Dinarvand, Life sciences,",
      "citeRegEx" : "239",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "L",
      "author" : [ "P.P. Komane", "Y.E. Choonara" ],
      "venue" : "C. du Toit, P. Kumar, P. P. Kondiah, G. Modi and V. Pillay, Journal of Nanomaterials, 2016,",
      "citeRegEx" : "240",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and R",
      "author" : [ "D. Eshun", "R. Saraf", "S. Bae", "J. Jeganathan", "F. Mahmood", "S. Dilmen", "Q. Ke", "D. Lee", "P.M. Kan" ],
      "venue" : "Matyal, Journal of Applied Physiology,",
      "citeRegEx" : "241",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and C",
      "author" : [ "A. Kowalczuk", "R. Trzcinska", "B. Trzebicka", "A.H. Müller", "A. Dwora" ],
      "venue" : "B. Tsvetanov, Progress in Polymer Science,",
      "citeRegEx" : "242",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "and R",
      "author" : [ "A. Puri", "K. Loomis", "B. Smith", "J.-H. Lee", "A. Yavlovich", "E. Heldma" ],
      "venue" : "Blumenthal, Critical ReviewsTM in Therapeutic Drug Carrier Systems,",
      "citeRegEx" : "243",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "and K",
      "author" : [ "A. Akbarzadeh", "R. Rezaei-Sadabady", "S. Davaran", "S.W. Joo", "N. Zarghami", "Y. Hanifehpour", "M. Samiei", "M. Kouh" ],
      "venue" : "Nejati-Koshki, Nanoscale research letters,",
      "citeRegEx" : "244",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "and X",
      "author" : [ "C. Li", "H. Li", "Q. Wang", "M. Zhou", "M. Li", "T. Gong", "Z. Zhan" ],
      "venue" : "Sun, Journal of Controlled Release,",
      "citeRegEx" : "245",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and C",
      "author" : [ "K.M. Poole", "C.E. Nelson", "R.V. Joshi", "J.R. Martin", "M.K. Gupta", "S.C. Haws", "T.E. Kavanaugh", "M.C. Skal" ],
      "venue" : "L. Duvall, Biomaterials,",
      "citeRegEx" : "247",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "R",
      "author" : [ "R.H. Staff", "M. Gallei", "M. Mazurowski", "M. Rehahn" ],
      "venue" : "d. Berger, K. Landfester and D. Crespy, ACS nano,",
      "citeRegEx" : "248",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "and Y",
      "author" : [ "W. Cui", "R. Liu", "H. Jin", "P. Lv", "Y. Sun", "X. Men", "S. Yang", "X. Qu", "Z. Yan" ],
      "venue" : "Huang, Journal of Controlled Release,",
      "citeRegEx" : "249",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "and H",
      "author" : [ "Y. Teng", "H. Jin", "D. Nan", "M. Li", "C. Fan", "Y. Liu", "P. Lv", "W. Cui", "Y. Su" ],
      "venue" : "Hao, Bioactive Materials,",
      "citeRegEx" : "250",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "and R",
      "author" : [ "Y.E. Kurtoglu", "R.S. Navath", "B. Wang", "S. Kannan", "R. Romer" ],
      "venue" : "M. Kannan, Biomaterials,",
      "citeRegEx" : "251",
      "shortCiteRegEx" : null,
      "year" : 2009
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Organ ischemia is the underlying pathology for many clinical conditions including stroke, myocardial infarction, acute kidney injury, limb ischemia, solid organ transplantation, as well as cardiopulmonary and main arterial surgeries.(1) Considering only myocardial infarction as a major cause of death and disability on the globe and lack of effective cardioprotective therapy in clinical practice necessitates the development of new therapies.",
      "startOffset" : 233,
      "endOffset" : 236
    }, {
      "referenceID" : 6,
      "context" : "Rapidly developing field of nanotechnology offers promising future to overcome the issues related to pharmacological treatment of ischemic tissue.(7) Unique",
      "startOffset" : 146,
      "endOffset" : 149
    }, {
      "referenceID" : 11,
      "context" : "11 Decreased blood flow to the affected tissue or its rapid metabolization by liver decreases availability of the drug to the affected organ.(12) Considering other barriers, e.",
      "startOffset" : 141,
      "endOffset" : 145
    }, {
      "referenceID" : 17,
      "context" : "peroxidase, GSH-Px and glutathione-S-transferase (GST)) and non-enzymatic (such as glutathione) reactions.(18) There are also external sources of antioxidants such as herbaceous polyphenols which play an important role against oxidative stress by targeting different cellular signaling pathway and subsequently up-regulation of endogenous antioxidant defenses.",
      "startOffset" : 106,
      "endOffset" : 110
    }, {
      "referenceID" : 40,
      "context" : "Adapted from ref.(41) b) In vivo and ex vivo whole",
      "startOffset" : 17,
      "endOffset" : 21
    }, {
      "referenceID" : 51,
      "context" : "Se improves the activity of the selenoenzymes and delays onset and progression of neurodegenerative diseases.(52) In recent years Se NPs have attracted tremendous interest from the scientific community as novel candidates in the management of oxidative stress owing to unique their properties including low toxicity, lots of surface active centers, excellent surface activity, high catalytic efficiency and strong adsorbing ability.",
      "startOffset" : 109,
      "endOffset" : 113
    }, {
      "referenceID" : 56,
      "context" : "Carbon-based nanomaterials can generate ROS because of the presence of the heteroatoms in chemically modified nanocarbons.(57) On the other hand, carbon-based nanomaterials may also show ROS scavenging effects.",
      "startOffset" : 122,
      "endOffset" : 126
    }, {
      "referenceID" : 58,
      "context" : "based on radical adducts formation at sp 2 carbon sites, and its destruction during second adduct formation by electron transfer or hydrogen donation from functional groups.(59)",
      "startOffset" : 173,
      "endOffset" : 177
    }, {
      "referenceID" : 61,
      "context" : "Due to such catalytic property, fullerene can react with many superoxides without being consumed.(62) Antioxidant functionality of fullerene depends on its ability for absorbing electrons and their dispersing",
      "startOffset" : 97,
      "endOffset" : 101
    }, {
      "referenceID" : 66,
      "context" : "These fullerenes can pass the cell membrane and localize to the mitochondria which is the source of the oxygen free radicals.(67) It has also been proved that carboxyfullerenes prevented from mitochondrial membrane disruption and leakage, which is the triggering step in apoptosis.",
      "startOffset" : 125,
      "endOffset" : 129
    }, {
      "referenceID" : 71,
      "context" : "Graphene is a 2D monolayer of tightly packed carbon atoms with fascinating properties.(72) Chemical modification of graphene by hydroxyl, epoxyl or carboxyl groups provides graphene oxide (GO) with some versatile and attractive properties as compared to the pristine graphene.",
      "startOffset" : 86,
      "endOffset" : 90
    }, {
      "referenceID" : 87,
      "context" : "Regardless of their potential for industrial applications they can present cytotoxic.(89) However, there are studies which suggested a ROS scavenging effect related to the conjugated C==C chains on the CNT structure which is similar to the carotenoids.",
      "startOffset" : 85,
      "endOffset" : 89
    }, {
      "referenceID" : 91,
      "context" : "either water or oil.(95) Even though, polymeric NPs does not provide direct antioxidant effects, but their involvement in antioxidant activities for tissue protection after I/R injury have been studied.",
      "startOffset" : 20,
      "endOffset" : 24
    }, {
      "referenceID" : 94,
      "context" : "96, 97 In recent years, stimuli-responsive polymeric nanoparticles have shown great promise for treatment and detection of ischemic areas owing to changeability of their chemical structure and physicochemical properties in response to environmental stimuli including pH, ionic strength, temperature and light.(98) The unique properties of ROS responsive polymeric nanoparticle such as the alteration in solubility in response to ROS and dual pH and ROSinduced degradation make them excellent candidates for ROS-responsive drug release or imaging of ischemic regions.",
      "startOffset" : 309,
      "endOffset" : 313
    }, {
      "referenceID" : 118,
      "context" : "In addition, polymer-drug and -protein conjugates are also widely used on cancer treatment which could also be exploited for I/R injury treatments.(127)",
      "startOffset" : 147,
      "endOffset" : 152
    }, {
      "referenceID" : 120,
      "context" : "Adopted from ref.(129) c) The mechanism of the ultrasensitive ROS-responsive gas-",
      "startOffset" : 17,
      "endOffset" : 22
    }, {
      "referenceID" : 135,
      "context" : "143 Polymeric nanogels are water soluble and biocompatible materials with stable encapsulation properties.(144) Polymeric nanogels have been exploited for sustained and long-term delivery of protective agents to the ischemic tissue.",
      "startOffset" : 106,
      "endOffset" : 111
    }, {
      "referenceID" : 144,
      "context" : "150 In addition to drug delivery, some studies have used dendrimers for gene delivery to the various ischemic organs and through different administration routes.(153) For example, the PAMAM dendrimer coupled with arginine-grafted poly (disulfide amine) (ABP) (PAM-ABP) was applied in delivering the plasmid DNA with hypoxia response element (HR1) to the",
      "startOffset" : 161,
      "endOffset" : 166
    }, {
      "referenceID" : 158,
      "context" : "Among the various NPs used in potential diagnostic applications, IONPs are the only one which has been successfully incorporated into the clinical applications.(167) The IONPs with superparamagnetic property have extensively been applied as contrast agent for MRI because of their biocompatibility, high relaxivity, non-toxicity and nonimmunogenicity in biological systems.",
      "startOffset" : 160,
      "endOffset" : 165
    }, {
      "referenceID" : 163,
      "context" : "170, 171 SPIONs, as contrast agents on MRI, speed up the early diagnosis of ischemic lesions and assists on detecting the infraction core and penumbra regions.(172) Since the ultrasmall superparamagnetic iron oxide (USPIONs) are taken up by macrophages and inflammatory cells in the body, they can be used to trace them, too.",
      "startOffset" : 159,
      "endOffset" : 164
    }, {
      "referenceID" : 165,
      "context" : "the same brain section in the animal models proved the visualization of the macrophage infiltration into the ischemic region by USPION-enhanced MRI.(174) The SPION-enhanced MRI offers a non-invasive method for long-term follow up of inflammatory process and monitoring",
      "startOffset" : 148,
      "endOffset" : 153
    } ],
    "year" : 2017,
    "abstractText" : "Organ ischemia with inadequate oxygen supply followed by reperfusion (which initiates a complex of inflammatory responses and oxidative stress) occurs in different clinical conditions and surgical procedures including stroke, myocardial infarction, limb ischemia, renal failure, organ transplantation, free-tissue-transfer, cardiopulmonary bypass, and vascular surgery. Even though pharmacological treatment protect against experimental ischemia reperfusion (I/R) injury, there has not been enough success for their applications in patient benefits. The main hurdles in treatment of I/R injury are the lack of diagnosis tools for understanding the complicated chains of I/R-induced signaling events, especially in acute phase after ischemia, determining the affected regions of the tissue over time, and then, targeting and safe delivery of antioxidants, drugs, peptides, genes and cells to the areas required treatment. Beside the innate antioxidant and free radical scavenging properties of some nanoparticles, they show higher flexibilities in drug delivery and imaging purposes. This review highlights three main approaches on I/R injury targeting by nanoparticles; 1) antioxidant nanoparticles on reducing tissue oxidative stress, 2) targeted delivery of therapeutic agents to the ischemic regions or cells, and 3) imaging I/R injury at molecular, cellular or tissue level and monitoring its evolution using contrasts induced by nanoparticles. These approaches can also be combined to realize so called theranostics for providing simultaneous diagnosis of ischemic regions and treatments by targeted delivery.",
    "creator" : "Aspose Ltd."
  }
}